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Summary 
Embryogenesis, tissue formation, wound healing and tumor metastasis all require 
directed cell migration. Migration mechanics depend on the attachment of cells to the 
underlying matrix which is required for cellular movements and signaling. Focal 
adhesions are the major cell-matrix connections that aid in adhesion, spreading and cell 
motility. The extracellular matrix glycoproteins are linked to the actin cytoskeleton via 
the transmembrane receptors integrins. The cytoplasmic domain of integrins interacts 
with several cytoskeletal and regulatory proteins that are involved in the assembly of the 
adhesion complex and help in the functional regulation of the adhesion dynamics. 
Vinculin is an important structural and elementary component of the adhesion complex 
which plays a major role in the molecular architecture and regulation of these adhesion 
sites. Vinculin acts as a molecular scaffold since it interacts with numerous ligands and 
serves as a connecting link between the membrane and the actin cytoskeleton. Acidic 
phospholipids like PIP2 are important ligands whose interaction is known to structurally 
and functionally modulate vinculin.  
This work aimed at the analysis of acidic phospholipid mediated regulation of vinculin at 
the adhesion sites. Design and construction of a lipid binding deficient mutant “vinculin-
LD” allowed to characterize the mode of regulation of vinculin at the focal adhesions. 
Biochemical analyses showed that “vinculin-LD” failed to co-sediment with lipid 
vesicles while leaving its interaction with important ligands like actin and the vinculin 
head (Vh) intact. Cell biological analyses of “vinculin-LD” proved that the lipid binding 
is not required for the focal adhesion targeting as previously suggested. Analysis of the 
incorporation rates of this mutant by fluorescent recovery after photobleaching also 
indicated that the vinculin recruitment to focal adhesions is normal. However, cells 
expressing “vinculin-LD” had a serious delay in cell adhesion and spreading and the 
motility was grossly impaired on various extracellular matrices. Thus, PIP2 interaction 
with vinculin is not essential for its adhesion localization but vinculin acts as a lipid 
sensor greatly influencing the adhesion site dynamics mediated through PIP2. 
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1. Introduction 
1.1. Cell migration in maintenance and control of physiological processes 
Directed cell migration is a highly integrated process that accompanies an organism right 
from conception to death. It plays a central role in development and maintenance of 
several biological phenomena like embryogenesis, immune response, tissue repair, tumor 
formation and metastasis. The failure of cell migration or nondirectional cell motility can 
lead to pathological conditions and congenital defects. Understanding the basic 
mechanics of cell migration is also considered important in technological applications 
like cell transplantation or tissue engineering. 
1.1.1. Cell migration in embryogenesis  
During embryogenesis, cell migration choreographs all the morphogenetic processes 
ranging from gastrulation to development of the nervous system. Two major types of cell 
movements can be observed during embryonic development. The first involves mass cell 
migration with tissue moving in a coordinated manner and cells maintaining their 
cohesive contacts while moving. This process is known as convergent extension and is 
particularly seen in amphibians and fish. The second type requires the loss of cell-cell 
contacts as it involves migration of the individual cell through the extracellular matrix, as 
seen during epithelial to mesenchymal transition (EMT) and neural crest formation. The 
TGF-β superfamily, Wnt and FGF signaling have been implicated in these two types of 
cell movements but different members and signaling pathways have been specifically 
associated with each of them (Locascio and Nieto, 2001). 
1.1.2. Cell migration in homeostasis 
Immune response and tissue repair are two homeostatic processes in the body that 
involve cell migration. Leukocyte migration is the hallmark of immune response, 
controlled cell movement allows the interaction of the immune cells with the antigen by 
which they elicit functions like phagocytosis or antibody production (Manzanares and 
Sanchez-Madrid, 2004). Cells migrating to areas of insult are stimulated by chemokines 
which act as traffic signals that guide their path and initiate polarization (Sanchez-Madrid 
and Angel del pozo, 1999). 
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Tissue repair or wound healing requires the migration of fibroblast or vascular 
endothelial cells to the areas of injury. This process is also guided by several signaling 
molecules that promote cell motility and regulate the cytoskeletal machinery to aid in 
wound closure (Martin and Parkhurst, 2004). 
1.1.3. Cell migration in pathobiology 
Failure of cells to migrate during embryogenesis can lead to defective implantation in the 
uterus and cause loss of pregnancy. In later stages, inappropriate migration of cells can 
result in congenital anomalies in the brain causing epilepsy or mental retardation 
(Huttenlocher et al. 1994, Bielas and Gleeson, 2004). 
In adults, cell migration is involved in maintenance of biological processes like immunity 
and wound healing as stated earlier. Functional impairment of these processes due to 
defective cell migration can lead to serious pathologies. For example, chronic 
inflammatory disorders are caused by hyperactivity of the immune system when there is 
constant influx of inflammatory cells to sensitized areas in the body. Rheumatoid arthritis 
and Multiple sclerosis are such diseases caused by the disorganized immune system  
(Johnson et al. 2004). For biologists studying cancer, the major challenge is to identify 
the underlying molecular mechanisms that are involved in tumor metastasis (migration of 
tumor cells to different areas of the body). The molecules that switch cells to a metastatic 
state mostly are migration related proteins that either stimulate or propagate the process 
(Friedl et al. 2004, Ridley, 2000). 
1.1.4. Molecular mechanics of cell migration 
Cell migration is a highly coordinated, dynamic process. Understanding cell migration as 
a conceptualized cycle requires the knowledge of chemical and physical properties of 
various components and the thermodynamic, kinetic and mechanical changes during their 
assembly. The steps involved in the migration cycle and the molecular players and 
signaling pathways are detailed below. 
A) Cell polarization and protrusive machinery 
The initial response of a cell to a migratory stimulus is to polarize and obtain a spatial 
asymmetry which clearly distinguishes the cell front from the rear and indicates the 
direction of migration. The extended protrusions can be large, broad lamellipodia 
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containing a branching “dendritic” network of actin filaments or spike like filopodia with 
a backbone of actin filaments organized into long parallel bundles. The generation of 
both, lamellipodia and filopodia is driven by actin polymerization (Pollard and Borisy, 
2003).  
The protrusive machinery involves continuous actin polymerization at the leading edge, 
and is mediated through the Arp2/3 complex which binds to the sides or tips of a pre 
existing actin filament and induces the formation of new daughter filaments (Machesky et 
al. 1994). The Arp complex consists of seven subunits – two actin related proteins, Arp2 
and Arp3, along with five unique polypeptides, called ARPC1-5 (Robinson et al. 2001). 
Activation of Arp2/3 complex is performed by WASP/WAVE family members 
(Machesky and Insall, 1998) which are themselves regulated by the Rho family of small 
GTPases like rho, rac, cdc42 (Ridley, 2001). The actual pushing force is generated not by 
the elongation of actin filaments but by an “elastic Brownian ratchet” mechanism 
(Mogliner and Oster, 1996, Pollard and Borisy, 2003) in which the thermal energy bends 
the nascent actin filaments and the restoring force of the filament to straighten up renders 
the propulsive force. Several actin binding proteins regulate actin polymerization through 
various mechanisms, for example, profilin adds polymerization competent actin 
monomers, capping proteins inhibit filament elongation, ADF/Cofilin severs and 
depolymerizes actin filaments. Many proteins are involved in the maintenance of the 
actin filament polymerization like cortactin which stabilizes branches (Weaver et al. 
2001), or filamin A and α actinin which stabilize the entire network by cross linking actin 
filaments (Cunnigham et al. 1992). 
B) Attachment to the extracellular matrix (ECM) 
The extended protrusions are stabilized either by attachment to the ECM (via integrins) 
or to adjacent cells (via transmembrane receptors). At the cytoplasmic face the 
transmembrane receptors are linked to the actin cytoskeleton. These adhesions serve as 
traction sites for migration as the cells move forward over them. The integrins play a 
major role in cell-matrix adhesions and “inside-out” signaling. Upon activation these 
heterodimeric transmembrane receptors cluster, they undergo conformational changes to 
interact with the cytoskeletal and adaptor proteins and initiate the formation of an 
adhesion complex (Zamir and Geiger, 2001). Several enzymes like kinases and 
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phosphatases are involved in the regulation of the adhesions. Formation of small 
adhesions (focal complexes) seen in the leading edge which undergo fast turnover are 
regulated by rac and cdc 42 (Nobes and Hall, 1995). Cells with large integrin clusters 
tightly adhere and form strong focal adhesions which are present in the cell body and in 
slow-moving cells. They are regulated by rho mediated actin-myosin contraction (Nobes 
and Hall, 1995). These cell-matrix contacts both serve as traction sites and 
mechanosensors that signal from ECM and accordingly alter the cytoskeletal dynamics. 
The migratory speed is directly proportional to the tractional force exerted by each 
adhesion and the strength of the adhesion is related to the density of the adhesion 
receptors in the cell (Lauffenburger and Horwitz, 1996, Galbraith et al. 2002). 
The formation and dissociation of focal adhesions involves kinetics and differential 
regulation of the molecular components, a highly complex process that is not completely 
understood (Zamir and Geiger, 2001). The main aim of this work is to analyse one such 
structural and regulatory protein – vinculin which is involved in adhesion turn over and 
will be discussed in greater detail in the following chapters.  
C) Cell body translocation, adhesion disassembly and detachment at the cell rear 
Translocation of the cell body is believed to occur due to a combination of traction forces 
generated by adhesions and rho mediated actomyosin contractility (Huttenlocher  et al. 
1995 and Jay et al. 1995). Rapid migration requires efficient mechanisms to release 
adhesions at the cell rear. In fibroblasts, a process called “membrane riping” leads to 
adhesion release where a major fraction of integrins is left on the substratum when the 
cell moves forward. Integrins that undergo regulated release can disperse and form 
endocytic vesicles in the cell body or remain aggregated, move forward along the edge of 
the cell and form new adhesions (Lauffenburger and Horwitz, 1996). The mechanism by 
which adhesion dissociation in the cell rear occurs includes a mechanical force arising 
from signaling pathways and involves regulatory components that influence adhesion 
turnover. Rho GTPase is strongly implicated in this process. Inactivation of rho by either 
inhibition or physiologic regulators induce cytoskeletal breakdown and inhibited 
migration in various cell types (Riento and Ridley, 2003). Several observations also 
indicate a role for tyrosine phosphorylation in adhesion release (Crowley and Horwitz, 
1995). p125 focal adhesion kinase (FAK) and Src tyrosine kinases are involved in focal 
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adhesion turn over (Carragher and Frame, 2004) and selective inhibition of Src kinase has 
been shown to decrease focal adhesion disassembly (Webb et al. 2004).  
 
 
 
 
  
Figure 1.1: Cell migration at a glance 
Cell migration involves the interplay of several signaling, cytoskeletal proteins. Initial 
protrusion is guided by actin polymerization; cell body translocation after adhesion to the 
ECM is driven by the tractional force generated from the adhesion sites and also through 
actin filament contraction. Adhesion disassembly and detachment at the cell rear rather 
involves myosin-mediated actin filament contraction than tractional force (modified after 
Lauffenburger and Horwitz, 1996). 
1.2. Cell adhesion 
Cell adhesion is a dynamic process that is crucial for the formation and maintenance of 
tissues. At these cell contact sites, the extracellular domains of transmembrane adhesion 
receptors interact with their corresponding ligands in the adjacent cell or in the extra 
cellular matrix, and the cytoplasmic domain is linked to the cytoskeleton. Linkage of the 
cytoskeleton to the adjacent cell or to the ECM gives mechanical strength to tissues and 
serves as anchor points for cytoskeletal movements that mediate changes during tissue 
development and morphogenesis (Pokutta and Weis, 2002). The proteins involved in cell 
adhesion mechanisms are typically divided into three classes (1) Cell adhesion 
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molecules/receptors which are transmembrane glycoproteins that mediate cell-cell or 
cell-ECM interactions namely integrins, cadherin, immunoglobulin, selectin and 
proteoglycan (eg: syndecan) superfamilies. (2) ECM proteins that are large glycoproteins 
including collagens, fibronectins, laminins and proteoglycans that assembles into fibrils. 
(3) Cytoplasmic plaque/peripheral membrane proteins such as catenins of the cell-cell 
contact sites and the cytoskeletal proteins like vinculin, talin that form a linkage between 
the adhesion complex and the actin cytoskeleton (Gumbiner et al.1996).  
1.2.1. Types of cell adhesions 
Cell-cell adhesions can be classified into communicating junctions, such as gap 
junctions, anchoring junctions, such as desmosomes and adherens junctions, and 
occluding junctions, such as zonula occludens or tight junctions.  
Gap junctions: Gap junctions are intercellular structures allowing for the passive diffusion 
of the ions and small molecules in aqueous intercellular channels (connexons) between 
the cytoplasms of the neighbouring cells (Kumar and Gilula, 1996). Most cells of the 
normal tissues, except skeletal muscle cells communicate via these junctions. The 
channels are constructed by at least 13 different proteins called connexins. 
Desmosomes: Desmosomes are specialised junctional structures that form a tight 
connection between all the epithelial cells and cardiac myocytes (Schwarz et al. 1990). 
They are linked to cytokeratins, a class of intermediate filaments. Desmosomal structures 
consist of several transmembrane glycoproteins like desmogleins, desmocollins (cadherin 
superfamily) and desmoplakins that link the intermediate filaments to the membrane. The 
cytoplasmic plaque protein associated with desmosomes is plakoglobin (Garrod, 1993). 
Adherens junctions: Cadherin-based cell-cell contact is a specialised region of the plasma 
membrane, where cadherin molecules of the adjacent cells interact in a calcium-
dependent manner. Actin filaments are associated with this structure through catenins 
located at the undercoat of the adherens junction (Geiger and Ginsberg, 1991). Classical 
cadherins are of three types epithelial (E), placental (P) and neuronal (N). α catenin is the 
only catenin that forms either direct or indirect linkage to actin cytoskeleton through  
α-actinin, vinculin, ZO-1, spectrin and a number of other molecules associated to 
cadherin complex (Yamada and Geiger, 1997). E-cadherin binds to β catenin or to γ 
catenin (plakoglobin) which, in turn, form the linkage to α catenin. 
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Tight junctions: In epithelial and endothelial cells, tight junctions are the most apical 
intercellular junctions that function as selective (semipermeable) diffusion barriers 
between individual cells. They maintain the different composition of proteins and lipids 
between the apical and basolateral plasma membrane domains and regulate the growth 
and differentiation of the cells (Tsukita et al. 1999). The proteins involved are integral 
membrane proteins, such as occludin, claudin and junctional adhesion molecule, JAM 
and peripheral membrane proteins such as ZO-1, 2, 3 etc. 
Cell-matrix adhesions can be classified into focal adhesions, dystroglycan complex and 
hemidesmosomes. 
Focal adhesions: Focal adhesions are the structural connections between the ECM and the 
actin cytoskeleton. Please refer to chapter 1.2.2 for detailed description. 
Hemidesmosomes: Hemidesmosomes are multimeric protein complexes that attach 
epithelial cells to their underlying matrix, via keratins. They are morphologically similar 
to desmosomes and localised to the basal surface of some epithelial cell types (Garrod, 
1993). Keratin bundles associate to the hemidesmosome plaque via proteins like BP230, 
BP180 and α6β4 integrin. 
Dystroglycan complex: The transmembrane adhesive receptor dystroglycan binds to laminin 
in the matrix and links it to the actin cytoskeleton. Dystrophin is the cytoplasmic plaque 
protein that aides in the linkage. Duchennes muscular dystrophy is caused by a mutation 
in the dystrophin gene (Campbell, 1995). 
1.2.2. Molecular model of cell-matrix adhesions 
Cells in culture and stationary cells adhere tightly to the underlying substratum through 
distinct regions of their plasma membrane called cell-matrix junctions, also termed as 
focal contacts or focal adhesions (FAs). Thirty years back FAs were described as 
structurally defined cell-matrix contact sites using interference reflection and electron 
microscopy (Abercrombie et al. 1971, Izzard and Lochner, 1980). At these sites the 
transmembrane receptors, the integrins, interact with extracellular matrix (ECM) proteins 
e.g. fibronectin, collagens, laminins or vitronectin. On the cytoplasmic face of the focal 
adhesion, integrins are linked to the actin cytoskeleton through various cytoskeletal and 
adaptor proteins. Focal adhesions are considered structural connections between the ECM 
and actin cytoskeleton. A schematic model of these structures is depicted in Figure 1.2. 
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The focal adhesions of the cultured cells are typically 2-5 µm long and 0.25-0.5 µm wide. 
The molecular complexity of these adhesion sites is surprisingly large, many of the 
components are still unknown, and many undergo proteolytic processing and 
conformational changes which regulates the formation and dissociation of these sites. 
Classification of these proteins based on their presumed functions categorizes them into 
following major classes (Zamir and Geiger, 2001).  
1.2.3. Players and regulators of cell-matrix adhesions 
Cytoskeletal proteins like vinculin, talin, α actinin, paxillin, tensin, parvin/actopaxin, 
can directly bind, cap, bundle or nucleate actin filaments and/or directly interact with 
cytoplasmic tails of integrins, thus serving the structural linkage between integrins and 
stress fibres. 
Regulatory proteins include various tyrosine kinases, serine/threonine kinases, tyrosine 
phosphatases, modulators of small GTPases and other enzymes.  
p125 focal adhesion kinase (FAK) and src family tyrosine kinases are activated in FAs 
and play an important role in their assembly. A number of proteins in the focal adhesion 
are highly tyrosine phosphorylated and inhibition of tyrosine kinases or serum starvation 
prevents the assembly of FAs (Burridge et al. 1992, Keely et al. 2004). Protein kinase C 
is involved in the regulation of FAK and Src kinases (Nakashima et al. 2002). 
Phosphotidyl inositol kinases like PI3K and PI5K are implicated in the regulation of PIP2 
and PIP3 levels in FAs, which will be discussed in detail in later chapters. Small GTPases 
of the rho family control the turnover of contact sites (Ridley and Hall, 1992, Rottner et 
al. 1999). Modulators of these small GTPases localized in FAs are probably involved in 
their regulation (e.g. GRAF, ASAP1). Enzymes like calpain proteases are known to 
regulate FAs by proteolysis of talin, paxillin,  FAK, Src and tensin (Carragher et al. 1999, 
Chen et al. 2000). 
Phosphotidyl inositols play a key role in FA regulation by binding to structural as well 
as regulatory proteins. PIP2 modulates the activity of many actin regulatory proteins that 
orchestrate actin polymerization to initiate locomotion. The mechanisms by which PIP2 
regulates the actin dynamics are described in Chapter 1.4. Actin cross linking proteins (α 
actinin, filamin) and membrane linking (vinculin, talin) proteins are also known to be 
                                                                                                             1. Introduction 10
regulated by PIP2. PIP3 influences the activity of many rho GTPases and their 
modulators (Yin and Janmey, 2003). 
Focal adhesions are sites through which cells respond to the ECM with diverse 
biochemical and biophysical properties. They also aid in intracellular signaling. The 
exact composition of a given FA therefore will differentially regulate cell adhesion, 
migration and proliferation. More knowledge of the composition and functional 
regulation of these components are required to better understand cell migration, adhesion 
during development, morphogenesis and maintenance of several biological processes. 
 
                        
Figure 1.2: Molecular model of a focal adhesion 
Simple model of a focal adhesion depicting only a few important structural components. 
The transmembrane receptor, integrin, is activated by binding to respective ECM protein. 
Linkage to the actin cytoskeleton is mediated through several cytoskeletal proteins 
(vinculin, talin, α actinin) which aid in the construction and in maintaining the physical 
integrity of the focal adhesion (Zamir and Geiger, 2001).  
1.3. Vinculin – a structural and regulatory component of focal adhesion 
Vinculin (“vinculum” meaning “link” in latin) was first reported as an intracellular 
protein isolated from chicken gizzard smooth muscle and was shown to be concentrated 
on the ventral surface of the chicken fibroblasts where they formed focal adhesions to the 
substratum (Geiger, 1979, Geiger et al. 1980). Functionally it was supposed to participate 
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in the linkage of the termini of the microfilament bundles to the plasma membrane 
(Geiger et al. 1980). It is one of the highly conserved cytoskeletal proteins with more 
than 95% homology between human and avian species (Weller et al. 1990). Vinculin 
provides a structural and functional link between the cell adhesion receptors (integrins or 
cadherins) and the actin cytoskeleton (Jockusch and Rudiger, 1996). Vinculin null mice 
die in early embryogenesis (E8-E10), due to heart and brain defects suggesting its 
requirement for the complex array of cell contacts and movements that occur during 
development (Xu et al.  1998). Loss of vinculin activity in C. elegans leads to defects in 
muscular activity and lethality at the larval L1 stage (Barstead and Waterston, 1991).  
Electron microscopic studies of chicken vinculin show a trilobar “head” 80 Å in diameter 
from which a long flexible “tail” emanates consisting of four distinct globular masses, 
connected by a short hinge region (Molony and Burridge, 1985, Winkler et al. 1996). The 
molecular weight of vinculin is 117kDa; it consists of 1066 amino acids (Coutu and 
Craig, 1988). Biochemical studies show that cleavage by V8 protease within the proline 
rich hinge region (residues 837-878) generates a 95kDa globular N-terminal head (Vh) 
and a C-terminal tail (Vt) (Price et al. 1989). 
1.3.1. Molecular structure of vinculin 
Bakolitsa et al. have recently elucidated the crystal structure of the full length vinculin 
molecule (Baklolitsa et al. 2004). They describe vinculin as a ‘bundle of bundles’ with 
dimensions 100×100×50 Å, made up of five domains with an autoinhibited conformation 
in which the C-terminal vinculin tail domain is held pincer-like by the vinculin head, and 
the ligand interactions are regulated both sterically and allosterically.  
Domains 1 – 3 (D1 – D3), made up of residues 6 – 717, comprise the vinculin head (VH) 
observed in the electron microscopic images, which is distinct from the proteolytic 
fragment ‘Vh’ which includes D4 and part of the proline rich region. Each domain within 
VH (D1, D2, and D3) consists of two four helix bundles, which are organized into three 
tandem pairs, which resemble the N-terminal fragment of α catenin termed as ‘vinculin/α 
catenin repeat’ (VCR). In domains D1 and D2 the two four helix bundles pack end-to-
end, in D3 the two bundles interact along their sides with a distinct break in helicity in the 
middle of the central helix.  D1 and D3 form a pair of pincers which are locked in 
position by D2. The pincers hold Vt (domain 5) in the autoinhibited structure (Fig: 1.3).  
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Domain 4, residues 719 – 835, is a four helix bundle that packs end-to-end with domain 5 
(Vt) and is considered to be the ‘neck’ region with variable conformation observed in the 
EM images. D4 precedes the proline rich region which is partly disordered (residues 838 
– 878) and a ‘strap’ (residues 878 – 890) that precedes the Vt domain (Fig: 1.3). 
The Vt domain, D5 (residues 896 –1066) is held in position by D1 and D3, the 
conformation of which is essentially identical to that seen in the tail crystal structure 
described below. The domains D4 and D5 together make the fourth VCR with a large 
insertion comprising the proline-rich region and the first helix of Vt. Vt makes two 
contacts with the vinculin head and one with the neck. According to Bakolitsa et al. the 
ligand binding sites on the head, tail and proline-rich regions are structurally distinct, but 
conformationally and thermodynamically linked. Therefore, activation of vinculin could 
be achieved by a combinatorial influence of ligands in distinct regions of the molecule, 
and when the activating potentials exceed the intramolecular binding energy, the 
molecule is transformed into the activated open state. Izard and colleagues have shown 
that talin binding induces marked conformational changes in the vinculin head 
(Domain1), converting the helical bundle structure, and displaces Vt from Vh (Izard et al. 
2004).  
                  
Figure 1.3: Molecular structure of vinculin 
Full length vinculin in its autoinhibited state, domains (D1 –D5) are shown in different 
colors. Major ligand binding sites are indicated (adopted from Bakolitsa et al. 2004). 
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1.3.2. Molecular structure of vinculin tail 
The crystal structure of Vt, residues 879 – 1066, was elucidated prior to the full length 
structure (Bakolitsa et al. 1999). The structure comprises a helical bundle, consisting of 
five helices (H1 to H5), connected by short loops (3-8 residues) and adopts an antiparallel 
topology (Fig 1.4A). All five helices are markedly amphipathic, with their hydrophobic 
side chains pointing inside and hydrophilic groups pointing outward. Positive charges 
cluster in two regions on the surface of the domain, a basic collar surrounding the C-
terminal hairpin and a basic ladder that is centered on H3, these basic clusters are 
identified as the putative acidic phospholipid binding sites (Bakolitsa et al. 1999)  
(Fig 1.4B). A C-terminal arm following the last helix is divided into three segments, a 
flexible loop (1047 – 1052), a β clamp (1053- 1061), and a hydrophobic hairpin (1062 – 
1066). The hydrophobic hairpin comprising amino acids TPWYQ is implicated in the 
membrane insertion of the molecule (Bakolitsa et al. 1999). The structural model 
suggests that Vt switches between a soluble helical bundle and a membrane bound 
unfurled form probably through the binding to acidic phospholipids. This assumption is 
also supported by the evidence that PIP2 binding increases the susceptibility of Vt to 
proteases. The authors also considered that vinculin head controls the ligand binding to 
Vt allosterically by stabilizing the helical bundle and preventing unfurling which was 
proved later with the description of full length vinculin structure. 
 
     
 
 
 
 
Figure 1.4 A: Structure of vinculin tail 
Stereo ribbon representation of Vt. Helices are 
shown in spectral colors from blue to red and 
labeled H0–H5. The side chains of all aromatic 
residues are shown as ball-and-stick and colored by 
atom type (adopted from Bakolitsa et al. 1999).  
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Figure 1.4 B : Molecular surface of vinculin tail 
Solvent-accessible surface of Vt, with salient features indicated. The basic ladder 
includes residues K944, R945, K952, K956, R963, K966, K970, R978, R1008, and 
R1049. The basic collar includes residues R910, K911, R1039, K1049, R1060, and 
K1061. The acidic cluster includes residues D1013, E1014, E1015, E1017, and E1021. 
The hydrophobic hairpin comprises the C-terminal residues 1062–1066 (TPWYQ). The 
crevice is formed by the H4-H5 turn, the H2-H3 turn, and H0. The coloring is according 
to electrostatic potential, blue for positive, red for negative (adopted from Bakolitsa et al. 
1999). 
1.3.3. Ligand interactions of vinculin 
The ligand binding properties of vinculin are influenced by an intramolecular head-tail 
interaction (Jockusch and Rudiger, 1996). The vinculin head has binding sites for α 
actinin, an actin cross linking protein (Kroemker et al. 1994), talin, a cytoskeletal protein 
which can directly bind the β subunit of integrin (Burridge and Mangeat, 1984, Johnson 
and Craig, 1994), and vinculin tail which mediates the intramolecular interaction 
(Johnson and Craig, 1994, Miller et al. 2001, Weekes et al. 1996). In addition to the head 
domain the vinculin tail can bind to the following proteins: paxillin, an adaptor protein 
(Turner et al. 1990, Wood et al. 1994), F-actin (Menkel et al. 1994, Huttelmaier et al. 
1997, Jockusch and Isenberg, 1981), Phosphotidylinositol 4,5-bisphosphate (PIP2) 
(Fukami et al. 1994, Johnson et al. 1998, Niggli and Gimona, 1993), as well as the lipid 
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bilayer proper (Bakolitsa et al. 1999, Johnson et al. 1998), and protein kinase C (Ziegler 
et al. 2002, Weekes et al. 1996). The proline rich neck region can bind to VASP (Brindle 
et al. 1996, Reinhard et al. 1996), ponsin (Mandai et al. 1999), vinexin (Kioka et al. 
1999) and the Arp2/3 complex (Demali et al. 2002) (Figure 1.5). The intramolecular 
head-tail interaction masks the binding sites for α actinin (Kroemker et al. 1994), talin 
(Johnson and Craig, 1994), actin filaments (Johnson and Craig, 1995), VASP 
(Huttelmaier et al. 1998) and the Arp2/3 complex (Demali et al. 2002) and prevents the 
interaction of these ligands with vinculin in its non activated ‘closed’ conformation.  
            
 Figure 1.5: Ligand interactions of vinculin 
Schematic diagram showing vinculin head (Vh), proline rich neck region (PRR), vinculin 
tail (Vt) and their respective ligand binding sites (based on Jockusch and Rudiger, 1996, 
Zamir and Geiger, 2001). 
1.3.4. Acidic phospholipid mediated regulation of vinculin 
Interaction of the acidic phospholipid, PIP2 with vinculin has been reported earlier 
(Fukami et al. 1994). Influence of PIP2 on vinculin’s intramolecular interaction was 
elaborately studied by several groups. Initially, PIP2 was reported to dissociate the 
vinculin head-tail interaction, subsequently unmasking its talin-and actin-binding sites 
(Gilmore and Burridge, 1996). Later, Weeks et al. showed that acidic phospholipids 
inhibit the intramolecular association and expose a cryptic actin binding site and protein 
kinase C phosphorylation sites in the vinculin tail (Weekes et al. 1996). PIP2-mediated 
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release of the head-tail interaction was therefore considered important for the focal 
adhesion targeting and assembly of FAs (Gilmore and Burridge, 1996). A conformational 
change in the vinculin tail due to PIP2 binding was also noticed earlier (Bakolitsa et al. 
1999) and was considered essential to decrease the affinity between Vh and Vt. The 
above model has been questioned by the recent findings that indicate the role of talin 
(Bass et al. 1999, DiPaolo et al. 2002) and other ligands that influence vinculin activation 
through their steric and allosteric interactions (Bakolitsa et al. 2004). Thus, the role of 
PIP2 as the sole activator of vinculin seems to be not significant any more, though it 
surely has a pivotal role in the regulation of the molecule in the adhesion sites (this 
work). Polyphosphoinositides have also been shown to inhibit the interaction of vinculin 
with actin filaments in vitro (Stiemle et al. 1999). The authors also suggested that actin 
and PIP2-binding to vinculin tail is mutually exclusive and the role of PIP2 is to expose 
talin binding site in Vh, while block the actin binding site in Vt. However, comparison of 
actin and PIP2-mediated changes in the molecular structure of vinculin indicates that 
these ligands may provide two alternative pathways to activation (Bakolitsa et al. 2004).  
1.4. Phosphatidylinositol 4,5-bisphosphate as a signaling molecule 
Phosphatidylinositol 4,5-bisphosphate (PIP2) and phosphatidylinositol 3,4,5 bisphosphate 
(PIP3) represent less than 1% of membrane phospholipids, yet they play a pivotal role in 
a number of crucial cellular processes. PIP3 is the effector of multiple downstream 
targets of the phosphotidylinositol 3 kinase (PI3K) pathway. PIP2 acts as the source of 
two important second messengers in the cell (Berridge et al. 1984), diacylglycerol (DAG) 
and inositol 1,4,5-trisphosphate (IP3). Role of PIP2 in the regulation of the actin 
cytoskeleton (membrane attachment to the cytoskeleton, phagocytosis) and its 
involvement in membrane trafficking (endocytosis, exocytosis), cell signaling (protein 
kinase localization and activation, ARF GTPase regulation) have now been well 
documented. PIP2 acting as an important regulator of actin dynamics is described in 
detail below. 
PIP2 modulates the activity of many actin regulatory proteins that orchestrate actin 
polymerization and promotes cell migration. Actin polymerization can be regulated by 
three different mechanisms of which all are potentially regulated by PIP2. One 
mechanism involves the Arp2/3 complex, that is known to promote actin nucleation and 
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filament branching. The complex is stimulated by WASP family proteins that are 
activated by PIP2 synergistically with other ligands (Rohatgi et al. 2000, Rozelle et al. 
2000). The second mechanism involves uncapping of the plus end of preexisting actin 
filaments by the dissociation of capping protein, CapZ which is promoted by PIP2 (Heiss 
and Cooper, 1991, Schafer et al. 1996). The third mechanism uses severing of preexisting 
filaments by gelsolin family proteins or cofilin/actin depolymerizing factor (ADF) to 
increase the number of actin nuclei. Cofilin/ADF severing activity is inhibited by PIP2 
(Ojala et al. 2001). Gelsolin has more potent severing activity than Cofilin/ADF. It is 
activated by Ca2+ to sever and cap filaments. Once bound to actin, gelsolin cannot be 
dissociated by decreasing the ambient Ca2+ concentration. Phosphoinositides and 
lysophosphatidic acid are the only known agents that can dissociate gelsolin from the 
filament ends (Janmey and Stossel, 1987, Meerschaert et al.1998).  
PIP2 also regulates key molecules involved in actin-membrane linkages. Many actin 
cross-linking and membrane attachment proteins are regulated by PIP2. Alpha actinin, is 
activated by PIP2 binding through dissociation of an intramolecular interaction which 
enables it to bind actin and titin (Young and Gautel, 2000). Filamin, another actin cross 
linking protein is inhibited by PIP2 (Furuhashi et al. 1992). Ezrin/Radixin/Moesin (ERM) 
proteins, like alpha-actinin, are activated by PIP2. The binding site for actin filaments 
(Nakamura et al. 1999, Barret et al. 2000) and transmembrane proteins (Hirao et al. 
1996, Heiska et al. 1998) in the ERM family proteins are exposed by PIP2 interaction.  
Focal adhesion proteins talin and vinculin are also activated by PIP2. In case of talin, 
PIP2 binding increases its affinity to the cytoplasmic domain of beta 1 integrins (Martel 
et al. 2001). PIP2 mediated vinculin activation has already been described in the earlier 
chapters. Thus, PIP2 plays a very significant role as a signaling molecule, in control and 
maintenance of various cellular processes. 
1.4.1. Synthesis and regulation of PIP2 in cells 
Phosphatidylinositol 4,5-bisphosphate (PIP2) has been shown to be maintained at 
relatively constant levels in cells (McLaughlin et al. 2002). Growth factor stimulation or 
cell adhesion to ECM cause rapid changes in cellular PIP2 levels (Auger et al. 1989, 
Weernink et al. 2000). Although localized PIP2 production is difficult to quantify, 
biochemical methods and single cell imaging with PIP2 specific antibodies or with the 
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PH domain of PLCδ fused to GFP have been successfully employed (Balla et al. 2000, 
Miyazawa et al. 1988). However, these methods only detect PIP2 changes on the palsma 
membrane. The major goal of current research is focused on mechanisms that are 
involved in PIP2 generation and its regulation. Two major mechanisms by which PIP2 
levels are modulated are considered to be either the localized synthesis by 
phosphoinositide kinases (PIPK) or the release of the electrostatically sequestered PIP2 
(McLaughlin et al. 2002).  
The PIP kinases are divided into three subfamilies type I, II, and III, according to their 
signaling specificity. The type I and II PIP kinase subfamilies include three isoforms α, β, 
and γ as well as a number of splice variants classified based on their substrate usage and 
subcellular targeting (Ishihara et al. 1996, Ishihara et al. 1998, Itoh et al. 2000). Type I 
PIP kinase activity has been shown to be necessary in actin rearrangements, adhesion, 
secretion, endocytosis, and ion channel regulation (Arneson et al. 1999, Di Paolo et al. 
2002, Ling et al. 2002, Shibasaki et al. 1997, Shyng et al. 2000). PIPKIγ is specially 
noted for its isoform and splice variant specific function. It has two known mRNA splice 
variants, PIPKIγ 635 and PIPKIγ 661, which differ by 26 amino acids in the C-terminus 
(Ishihara et al. 1998).  Recent results showed that PIPKIγ 661 targets to FAs and interacts 
with the FERM domain of talin (Di Paolo et al. 2002, Ling et al.  2002). This suggests a 
novel role of PIP kinases as potential regulators of cellular processes like adhesion and 
migration. In turn, several small G proteins like RhoA, Rac1, and ARF6 are considered as 
potential regulators of PIP kinases (Doughman et al. 2003). 
Proteins that sequester PIP2 should satisfy the essential criteria, like-their availability in 
high concentrations at the membrane associated areas and having high electrostatic 
affinity for PIP2. MARCKS (Myrsitolated alanine rich C-kinase substrate) is considered 
to be the best candidate, found attached to the membrane and having high affinity to PIP2 
(Mclaughlin et al. 2002). Several signals that initiate increase in PIP2 levels could 
probably modulate these sequestering proteins and trigger the release of PIP2 but more 
elaborate analyses are needed to understand the molecular mechanism. 
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1.5. Aims of this work 
As pointed out at the beginning of this section, cell adhesion and migration are two basic 
physiological processes essential for development and maintenance of a living organism. 
Vinculin is a major structural and elementary component of cell-matrix adhesions, 
without which the above mentioned cellular processes are non-functional. Thus, the 
knowledge about the structure, regulation and dissociation of vinculin-containing 
building blocks at adhesion sites is essential for the understanding of tissue formation. 
Although the acidic phospholipid-mediated activation of vinculin has already been 
known for several years as stated earlier, important details regarding its regulation to 
influence the focal adhesion turnover was not completely solved. The primary goal of this 
work was to characterize the role of acidic phospholipids as major regulators of the cell 
adhesion protein vinculin. The problem was approached with a wider perspective in 
terms of characterizing the effect of acidic phospholipids on vinculin’s biochemical 
properties and its cellular functions. A ‘lipid binding deficient’ vinculin mutant was 
designed, and variations in its biochemical properties like acidic phospholipid binding, 
interactions with important ligands like F-actin and vinculin head domain were analysed 
and compared to wild type vinculin. The effects of the lipid binding site mutations on the 
structural and functional regulation of the molecule at the adhesion sites were also 
addressed by generating cell clones that stably express vinculin wild type and mutants as 
GFP fusion proteins. Functional processes like cell migration, adhesion, turnover of 
adhesion sites were the key points studied.  
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2. Materials and Methods 
 
2.1. Materials 
2.1.1. Chemicals and enzymes 
All chemicals were of p.A quality and purchased from Sigma (Deisenhofen), Serva 
(Heidelberg), Merck (Darmstadt), Fluka (Neu-Ulm), Difco (Hamburg), ICN (Eschwege) 
and Invitrogen (Karlsruhe). All enzymes employed in molecular biology were from the 
following companies unless otherwise specified, New England Biolabs (Bad 
Schwalbach), Stratagene (Heidelberg), Boehringer (Mannheim), Appligene (Heidelberg), 
Invitrogen (Karlsruhe) and Promega (Mannheim). 
2.1.2. Cell culture medium and plastic wares 
Cell culture media and additives were purchased from Gibco BRL and Sigma.  
Plastic wares were obtained from Corning, Eppendorf, Falcon, Greiner and Nunc. 
2.1.3. Oligonucleotides 
The Oligonucleotides employed in cloning and sequencing reactions were obtained from 
MWG-Biotech (Ebersberg). The cloning and mutagenesis primers are listed in Table 2.1 
and the sequencing primers are listed in Table 2.2 below. The restriction sites present in 
the primers are also specified. 
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Table 2.1: Cloning and mutagenesis primers  
Number Name Purpose Sequence 5’ to 3’ 
WZ 186 
 
Vt 858SacI sense Vt wt cloning AACTGATGAGCTCGCTCCTCCTAAGC  
  
WZ 190 Vt 1066XhoI,SalI 
reverse 
Vt wt cloning CTCGAGGTCGACTTACTGGTACCAGGG 
WZ 121 Vt 1052SalI reverse Vt ∆1052 
cloning 
AGGTCGACTCAAGCATCTGTTCGGATTTT 
WZ 234 Vh 1EcoRI sense Vh D1 cloning GAATTCATGCCAGTGTTTCATAC 
 
WZ 235 Vh 258SalI reverse Vh D1 cloning TACAGTCGACCTACCCAGGCATCTT 
 
WZ 100 Vt RK1060/61QQ sense Vt CT & LD 
mutagenesis 
CTCTGCGCTGGGTCCAACAGACTCCCTGGTATCAGTA 
 
WZ 101 Vt RK1060/61QQ 
reverse 
Vt CT & LD 
mutagenesis 
TACTGATACCAGGGAGTCTGTTGGACCCAGCGCAGAG 
 
WZ 200 Vt KK952/956QQ 
sense 
Vt H-3 & LD 
mutagenesis 
TTCAGTGTGCCCAGGATATCGCCCAGGCCTCTGATGA 
 
WZ 201 Vt KK952/956QQ 
reverse 
Vt H-3 & LD 
mutagenesis 
TCATCAGAGGCCTGGGCGATATCCTGGGCACACTGAA 
 
WZ 202 Vt RK963/966QQ sense Vt H-3 & LD 
mutagenesis 
CTGATGAGGTGACGCAGTTAGCCCAGGAGGTTGCCAAGC 
 
WZ 203 Vt RK963/966QQ 
reverse 
Vt H-3 & LD 
mutagenesis 
GCTTGGCAACCTCCTGGGCTAACTGCGTCACCTCATCAG 
 
WZ 313 PIP5K 1EcoRI sense PIP5K KD 
cloning 
GAATTCATGTCGTCAACTGCTG 
 
WZ 314 PIP5K 308stop/SalI 
reverse 
PIP5K KD 
cloning 
GTCGACTTACATGGCTGTGGAG 
 
WZ 188 Vin S842F sense Vinculin full-
length cloning 
CCTCAGGAGCCTGACTTCCCGCCTCCTCCACCAGAC 
WZ 189 Vin S842F reverse Vinculin full-
length cloning 
GTCTGGTGGAGGAGGCGGGAAGTCAGGCTCCTGAGG 
WZ 175 Vin G565E sense Vinculin full-
length cloning 
CGAGGGGAGGGGGAGAGTCCTCAGGC 
WZ 176 Vin G565E reverse Vinculin full-
length cloning 
GCCTGAGGACTCTCCCCCTCCCCTCG 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                           2. Materials and Methods 22
Table 2.2: Sequencing primers 
Number Name Purpose Sequence 5’ to 3’ 
WZ 179 Vh U0678 Vh sequencing CAAGGAATAGAAGAAGCTTTG 
WZ 180 Vh U0898 Vh sequencing CTGGAGAGCAGGCCATCAGG 
WZ 182 Vh L0321 Vh sequencing ATGAGGTAATCCCGTGCAGGAAC 
WZ 183 Vh L1237 Vh sequencing CTTCAGCCAAAGCCCCTCGAATCT 
WZ 160 Vh U1118 Vh sequencing GGAGAATGCAGCTCGGAAGCTGGA 
 
WZ 161 Vh U1338 Vh sequencing CTGACCTCTAAACTAGGAGACTTG 
WZ 162 Vh U1558 Vh sequencing TCGGTCAGGCTGCCATCCGTGGAC 
WZ 163 Vh U1778 Vh sequencing GCAGGAAGCTATGACTCAAGAGGT 
WZ 164 Vh U1998 Vh sequencing ATTCAGGCATCTGTGAAGACAGCC 
WZ 165 Vh U2232 Vh sequencing GTAGCCATGGCCAATATTCAGCCT 
WZ 192 Vh U2370 Vh sequencing GCTGCCTCTGATGAACTG 
WZ 193 Vt U2640 Vt sequencing CCCCCACCACCAGAAGAG 
WZ 194 Vt U2860 Vt sequencing TTCAGTGTGCCAAGGATA 
WZ 116 Vt U3052 Vt sequencing GTGATGAGGAGTCTGAGC 
WZ 199 Vt L2621 Vt sequencing CTGGGTGGAGGGACTTCA 
WZ 315 mmPIPkin U223 PIP5K KD 
sequencing 
GCACATCACTACCCAGACTTCAGG 
WZ 316 mmPIPkin U528 PIP5K KD 
sequencing 
GCAGTCAGGAGGCATCAACATC 
WZ 317 mmPIPkin L387 PIP5K KD 
sequencing 
ATAATAAATTCATCATCGCTGGTC 
WZ 318 mmPIPkin L704 PIP5K KD 
sequencing 
ATCGAAATACAGCCCCTCAT 
2.1.4. Vectors 
The PCR products were directly cloned into the pCR Blunt vector using the Zero Blunt 
PCR cloning kit (Invitrogen). The prokaryotic expression vector pQE 30 (Qiagen) was 
employed for recombinant protein expression in E. coli; the constructs also had N-
terminal coding sequences for the “Flag epitope” for detection in Western blot. 
The vinculin head domain (D1) was subcloned into pGex4T-1(Amersham biosciences) 
for GST fusion protein expression. 
 For the generation of vinculin full-length GFP fusion constructs, pEGFP-C2 (Clontech) 
vector was used. Mouse PIP5-kinase α cloned in the myc tagged vector  pRK5-Myc was 
kindly provided by Laura Machesky (University of Birmingham, Birmingham, UK) 
(Rozelle et al, 2000), the “kinase dead” mouse PIP 5-kinase α was fused to a BiPro tag 
(Rudiger et al, 1997) and subcloned into pcDNA3 (Invitrogen). Myc tagged L61-Rac in 
pRK5-Myc was a kind gift from Laura Machesky. 
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2.1.5. Bacterial cultures and cell lines 
The cloning and recombinant protein expression was performed in the E. coli strains  
XL-1 blue and M15 (pREP4). The strains had the following genotypic markers. 
 
XL-1 blue supE44 hsdR17 recA1 gyrA46 thi rel A1 lac- F’ [pro AB+ lacIq LacZ.M15 Tn10(tetr)]  
M15(pREP4) NalS, StrS, RifC, Thi-, Ara+, Gal+, Mtl-, F-, RecA+, Uvr+, Lon+ (Villarejo, 1974)  
The strains were grown in 2xYT medium containing the respective antibiotics depending 
on the vector used. 
 
2xYT medium :             16 g Tryptone (Difco)  
10 g Yeast extract (Difco)  
10 g NaCl  
                                               Made up to 1 litre with H2O  
For agar plates 16 g of Bacto agar was added to 1 litre medium. 150 µg/ml of ampicillin 
and 30 µg/ml of kanamycin were used in the liquid medium and plates. 
 
The cell lines employed in this study were ATCC strain of C2C12 mouse myoblasts, NIH 
3T3 mouse fibroblasts, and B16-F1 mouse melanoma cells  
(obtained from Dr. Theresia E. B. Stradal, GBF, Braunschweig). 
Mouse embryonic fibroblasts from vinculin null mice MEF-/- and the control fibroblasts 
MEF+/+ were kindly provided by Prof. Dr. David Critchley (University of Leicester, 
Leicester, UK). 
2.1.6. Antibodies 
Antibodies were mainly employed for immuno detection in western blots and in vivo 
imaging of cells by immuno fluorescence. 
The antibodies used in immuno blots are listed in Table 2.3, the antibodies and toxins 
used for immuno fluorescence are listed in Table 2.4 below. 
Table 2.3: List of antibodies used in immuno blots 
Description Antigen Company Organism Clonal type Dilution 
Anti Flag (M2) “Flag epitope” Sigma Mouse Monoclonal 1:10000 
Anti GST GST tag Sigma Rabbit Polyclonal 1:10000 
hvin1 Vinculin head Sigma Mouse Monoclonal 1: 1500 
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The secondary antibodies employed were HRP conjugated Goat anti mouse IgG (1: 5000) 
and HRP conjugated goat anti rabbit IgG (1: 5000) for detection using enhanced 
chemiluminescence (ECL). 
Table 2.4: List of antibodies and toxins used in immuno fluorescence 
Description Antigen/Source Company/Institution Organism Clonal type Dilution 
hvin1 Vinculin head Sigma Mouse Monoclonal 1: 500 
Anti paxillin Paxillin BD Biosciences Mouse Monoclonal 1: 500 
9E10 anti myc Myc tag GBF, Braunschweig Mouse Monoclonal Hybridoma 
supernatant 
4A6 anti BiPro BiPro tag TU-BS, Cell Biology dept Mouse Monoclonal 1: 10 
Alexa FluorTM594  
phalloidin 
Amanita 
phalloides 
Molecular Probes      -       - 1: 200 
Alexa FluorTM350 
phalloidin 
Amanita 
phalloides 
Molecular Probes      -       - 1: 200 
 
The secondary antibodies employed were  
A12c:  Goat anti Mouse IgG (H+L) coupled to Alexa FluorTM 488, 5 µg/ml in 1% BSA in 
PBS, 1:400 (Molecular Probes) 
A16c:  Goat anti Mouse IgG (H+L) coupled to Alexa FluorTM 350, 5 µg/ml in 1% BSA in 
PBS, 1:200 (Molecular Probes) 
Goat anti mouse IgG conjugated to TRITC (Sigma), 1: 200 
2.2. Methods 
2.2.1. Molecular biological methods  
2.2.1.1. Quantification of DNA 
DNA concentrations were determined photometrically. The maximum photometric 
absorption of RNA and DNA in solution is at 260 nm. The concentration of DNA in a 
diluted solution is calculated using the molar extinction co-efficient (ε at 260 nm = 50 
µg/µl) as given below 
OD260 × dilution factor × 50 µg/µl = Concentration of DNA µg/µl 
2.2.1.2. Restriction endonuclease digestion of DNA 
Restriction enzymes were purchased from New England Biolabs and the reaction was set 
up using the appropriate amount of enzyme in units as recommended by the manufacturer 
and 2.0-5.0 µg DNA was used for a preparative digestion. The reaction was performed in 
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the suitable 1× buffer provided by NEB. The reaction mix was usually incubated for 1-2 
hrs at 37°C if not otherwise indicated, as recommended by the manufacturer.  
For double digestions involving two non-compatible enzymes, temperature inactivation 
of the primary enzyme was done before subsequent digestion. 
2.2.1.3. Ligation 
The ligation reaction covalently links the phosphodiester bonds between two fragments 
of DNA using the ligase enzyme. DNA ligase from T4 Bacteriophage (Boehringer, NEB) 
was employed in this work to link vector DNA with the insert DNA. Appropriate molar 
ratios (usually 1:3) between vector and insert DNA were used in a 15 µl reaction with 1 
µl ligase and 1× T4 ligation buffer. The reaction mixture was incubated at RT for 1 hour. 
2.2.1.4. Transformation in competent cells 
The ligated DNA was transformed in chemically competent cells; E. coli strain XL1 Blue 
was used for this purpose. Cells were incubated for 30 minutes on ice with the ligation 
mixture, heat shock at 42°C was applied for 2 minutes and the cells were regenerated by 
adding 0.8 ml 2×YT medium and incubated at 37°C for 1 hour. The cells were pelleted 
down by centrifugation at 6000× g, resuspended in 100 µl medium and plated onto 2×YT 
agar medium containing appropriate antibiotics.   
2.2.1.5. Polymerase chain reaction (PCR) 
PCR is a technique employed for rapid in vitro amplification of DNA. The amplification 
is done using the temperature resistant DNA polymerase, free nucleotides, a primer or the 
starter sequence which specifically binds to the template strand and initiates the 
amplification. Three major steps involved in the reaction are, the denaturation of the 
template DNA at high temperatures (95°C), annealing or primer binding to the template 
strand at 55°C – 60°C and finally an extension step at 72°C for the actual amplification. 
For exponential increase of amplified DNA the steps are repeated for 25-30 cycles. 
DNA polymerase from the thermophilic bacteria like Thermus aquaticus (Taq) does not 
have the 3’ to 5’ exonuclease or “proof reading” property to prevent mutations. The DNA 
polymerases from Pyrococcus furiosus (Pfu) and Thermococcus litoralis (Tli) are used 
instead. 
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The standard PCR reaction mixture contained template plasmid DNA (ng concentration), 
primers specific to the template strand (25 pmol), free nucleotides or dNTP’s (2.5 mM), 
MgCl2 (0.5 – 2.5 mM), 1× PCR buffer and 2.5-5.0 units of DNA polymerase 
(Taq/Tli/Pfu) in 25 – 50 µl reaction volume. 
2.2.1.6. Site directed mutagenesis 
The QuikChange™ site directed mutagenesis kit from stratagene was employed to 
introduce mutations in vinculin. 
Oligonucleotide sequences with respective bases exchanged were used in a PCR reaction 
with the plasmid DNA and PfuTurbo DNA polymerase in 50 µl reaction volume. The 
PCR products were digested with the restriction enzyme Dpn1 at 37°C for one hour. 
Dpn1 specifically digests the methylated DNA used as template and retains only the 
newly synthesized DNA. The reaction mixture was then transformed in XL1 Blue 
competent cells and plated on to 2×YT agar medium with appropriate antibiotic selection. 
2.2.1.7. Preparation of plasmid DNA from bacteria 
Plasmid DNA expressed in XL1 Blue cells was prepared by modified alkaline lysis 
method (Birnboim, 1983). Plasmid mini preparations were performed using the Nucleo 
Spin plasmid extraction kit from Macherey-Nagel GmbH, Düren, plasmid midi- and 
maxipreparations were performed using Qiagen columns (Qiagen) according to the 
manufacturer’s recommendations. 
2.2.1.8. DNA sequencing reaction 
DNA Sequencing reactions were done with the ABI PRISM® Big Dye Reaction 
Terminator Cycle Sequencing Kit (Applied Biosystems) as per manufacturer’s 
instructions. The sequencing reaction products were precipitated with ethanol and 
analysed on an ABI PRISM™ TM 310 Genetic Analyzer (Applied Biosystems). 
ABIPRISM-sequence files were aligned using Seqman (Lasergene software). 
2.2.1.9. DNA extraction from agarose gels 
DNA was recovered from agarose gel slices with the QIAex Gel Extraction Kit (Qiagen) 
as per manufacturer’s instructions. 
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2.2.1.10. Cloning strategy – vinculin full length and tail domain constructs 
The full length mouse vinculin cDNA amplified from mouse heart cDNA library in 
pACT (BD Biosciences) and cloned into pEGFP-C2 vector was obtained from Dr. Stefan 
Hüttelmaier. Sequencing analysis identified several additional mutations in the clone. 
There were five mutations which resulted in the amino acid replacements in the protein 
sequence, namely, E16V (Glutamate 16 exchanged to valine), R501Q, E565G, D812G, 
F842S. The phenylalanine 842 to serine exchange was considered very critical for the 
protein function since it was in the FP4 motif involved in the ligand interactions. 
Comparison of protein sequence alignments of full length mouse vinculin, human 
vinculin and the cDNA clone eliminated the E16V, R501Q and D812G mutations, since 
the human vinculin also had the following replacements.  
The full length mouse vinculin was subcloned into pCR Blunt vector and site directed 
mutagenesis was performed to revert back the E565G, F842S mutations. Additionally, a 
silent mutation of L858 was done to introduce a SacI site for easier subcloning of tail 
domains (858-1066 AA) into full length vinculin (1-1066 AA). The pCR Blunt vector 
was modified to remove the SacI site present internally and this vector was employed in 
further subcloning’s with the vinculin tail domains. 
The vinculin tail wild type and the mutants (858-1066 AA) were generated by PCR 
amplification, cloned into the pCRBlunt vector. The pQE 30 vinculin tail wild type clone 
with the SacI site introduced at L858 was used for the subcloning of mutant tail domains. 
The pQE30 vinculin tail constructs were employed for the protein expression and 
purification. The full length vinculin wild type in pCR Blunt vector was digested with 
SacI and SalI (sequential digestion after heat inactivation) and the vinculin tail mutant 
inserts were ligated to obtain full length vinculin mutant constructs. 
2.2.1.11. Cloning of vinculin head domain (D1) 
Vinculin head domain D1 (1-258 AA) was generated by PCR amplification, cloned into 
the pCRBlunt vector and subcloned into a GST fusion vector pGEX 4T-1 (Amersham 
Biosciences) using EcoRI and SalI restriction cloning sites for prokaryotic expression and 
purification. 
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2.2.1.12. Cloning of PIP5K α “kinase dead” mutant 
The “kinase dead” mutant of PIP5K α which was a C-terminal deletion construct was 
generated by PCR amplification using the wild type PIP5K α, cloned into the pCR2.1 
vector (Invitrogen) and subcloned using EcoRI ad SalI restriction sites, into the pcDNA3 
vector fused to a BiPro tag. 
2.2.2. Biochemical methods 
2.2.2.1. Protein estimation 
2.2.2.1.1. Using molar extinction coefficient 
Amino acids containing aromatic side chains (i.e., tyrosine, phenylalanine and 
tryptophan) exhibit strong UV-light absorption and the amino acid cystine absorption do 
not vary under native conditions. Thus, concentration of protein solutions under native 
conditions could be derived from their molar extinction coefficient or molar absorptivity 
as stated below. 
Concentration (mg/ml) = Absorbance (OD280) / EM * Mol.wt 
EM (molar extinction coefficient) =aEM, Tyr + bEM, Trp + cEM, Cys  
Where a, b, c are the number of tyrosine, trytophan and cystine residues per mole of 
protein and Eresidue are the molar extinction of the residue at 280 nm (EM,Tyr = 5690, 
EM,Trp= 1280, EM,Cys = 120). 
2.2.2.1.2. Bicinchoninic acid (BCA) assay 
The BCA™ Protein Assay kit (Pierce, IL) was used for total protein estimation as per 
manufacturer’s recommendations. 
2.2.2.2. Sodiumdodecylsulphate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
Sodiumdodecylsulphate-Polyacrylamide gel electrophoresis (SDS-PAGE) was performed 
with a protocol adapted from Laemmli (Laemmli, 1970). SDS-PAGE gels casted 
contained the separating and stacking regions with varying pH and 1mm spacers were 
used. 10% separating gels were mostly employed in this work. The protein solutions or 
cell lysates were diluted in 4× SDS sample buffer, boiled at 95°C for 5 minutes and 
loaded in the gels. “High molecular weight marker” (HMW) from Sigma was used to 
determine the molecular weight. 
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2.2.2.3. Coomassie-Blue-staining of protein gels 
Gels were stained using 0.1% Coomassie R-250 Solution in 10% acetic acid and 25% 
isopropanol. For quick staining the gels were boiled with the staining solution in a 
microwave and 10 – 15 minutes incubation. Destaining was done using 10% acetic acid 
and 40% methanol at room temperature. 
2.2.2.4. “Semi dry” Western blot 
Proteins were transferred from the gels onto a nitrocellulose membrane using the semi -
dry blotting apparatus from Biometra. The membrane, gel and whatmann filter papers 
were equilibrated in the glycine-methanol buffer (25 mM Tris pH 8.5, 150 mM Glycine, 
10% Methanol) and the proteins were transferred from the gel (negative electrode) to the 
membrane (positive electrode) at 100mA per mini gel for 60 – 90 minutes. The efficiency 
of the transfer was monitored by staining the membranes with PonceauS solution (0.5% 
PonceauS (Sigma), 40% methanol, 15% acetic acid) and molecular weight marker bands 
were marked.  
Membranes were blocked for 30 minutes to 1 hour at room temperature or at 4°C 
overnight in blocking buffer (4% dry-milk in TBS-T buffer (20 mM Tris-HCl pH 7.6, 
140 mM NaCl, 0.1% Tween 20)). Afterwards, membranes were incubated for 1-1.5 hr at 
room temperature or at 4°C overnight in TBS-T buffer containing the primary antibody. 
Membranes were washed thrice for 10 minutes in TBS-T and incubated for 1 hour at 
room temperature in TBS-T buffer containing the secondary antibody, followed by 
another 4 washes as described above. Membranes were then incubated for up to 3 
minutes with the chemiluminescence substrates in the ECL kit (Amersham Biosciences) 
and exposed to Hyperfilm ECL (Amersham Biosciences) for 30 seconds – 1 minute. 
Films were developed manually using the Kodak developer and fixing solutions. 
2.2.2.5. CD Spectroscopy  
Proteins were diluted to 0.05 – 0.1 µg/µl in phosphate buffer (20 mM NaH2PO4 pH 7.2, 
0.5 mM EGTA) and measured using a 0.2 cm wide quartz cuvette in a spectropolarimeter 
(Jasco systems). The spectra was collected for 20 accumulations and used for analysis. 
                                                                                           2. Materials and Methods 30
2.2.2.6. Graphic representation of vinculin tail domains 
Graphic views of Vt (879-1061) based on PDB entry 1QRK were generated using 
SwissPDB viewer (http://www.expasy.ch/spdbv) and POVray 3.1 
(http://www.povray.org) on a Linux platform (courtesy: Dr. Jochen Kuper) 
2.2.2.7. Expression and purification of recombinant proteins 
Recombinant proteins fused to “His tag” or “GST tag”was employed in this work whose 
expression and purification procedures are detailed below. 
2.2.2.7.1. Expression of recombinant proteins 
The recombinant proteins constructs Vt wild type and mutants in pQE 30 vector (His tag)  
and vinculin head domain (D1) in pGEX 4T-1 vector (GST tag) were expressed in the 
M15 strain of E. coli (see 2.1.5). The main culture (1-2 L) was prepared by inoculating 20 
ml of pre culture in 2× YT medium containing kanamycin/ ampicillin resistance, 30 µg/µl 
L-Proline, 5 µg/µl Thiamine, 0,2 % Glycerine and incubated in a 37°C shaker (220 rpm). 
1mM IPTG was used for protein induction in the culture medium when the OD at 600 nm 
reaches 0.5. The proteins were allowed to express for 3 hours and the cells were collected 
by centrifugation at 6500 rpm, 4°C. 
2.2.2.7.2. Purification of His tagged protein using Ni-NTA agarose beads 
The “His” tagged proteins were purified by affinity purification using Ni-NTA agarose 
which specifically binds to the 6× Histidine residues in N-terminal protein sequence. The 
cells collected from one litre of main culture were dissolved in 20 ml of lysis buffer (50 
mM NaH2PO4 pH 8, 300 mM NaCl, 25 mM Imidazole, 0.5 % Tween 20 with fresh 
protease inhibitors, β-mercaptoethanol and 1 mg/ml lysozyme). The cells were subjected 
to ultrasonication for 30 seconds (5×) with 1 minute break in between the cycles.  The 
cell debris was collected by centrifugation at 15000 rpm for 30 minutes at 4°C. 4 ml of 
Ni-NTA agarose was equilibrated in lysis buffer; the cell lysate supernatant was added to 
the beads and incubated on ice for 1 hour with periodic shaking. The beads were then 
subjected to the washing steps, twice in 10 ml of lysis buffer, twice in 10 ml of washing 
buffer (50 mM NaH2PO4  pH 6.0, 300 mM NaCl, 0.5 % Tween 20, 8.7 % Glycerine with 
fresh protease inhibitors, β-mercaptoethanol). A final washing step with elution buffer 
without histidine was also performed. The protein bound to Ni-NTA beads were eluted in 
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5× 1 ml fractions of elution buffer (50mM NaH2PO4 pH 6.7, 100mM KCl, 0.5mM 
EGTA, 25mM EDTA, 0.1% Triton X 100 with freshly added 150mM Histidine, protease 
inhibitors, β-mercaptoethanol). The fractions were spotted on a nitro cellulose membrane, 
stained with PonceauS to detect the presence of the protein in the eluate fractions. The 
fractions were then subjected to desalting procedure using the PD-10 gel filtration 
columns (Amersham Biosciences). The protein was finally eluted in phosphate buffer 
(50mM NaH2PO4 pH 7.2, 0.2mM EGTA with fresh protease inhibitors, β- 
mercaptoethanol) from the gel filtration column.  
[Note: Protease inhibitors used were AEBSF, 0.2 M in H2O (1:500), PepstatinA, 1 mM in 
Ethanol (1:500), Leupeptin, 10 mM in H2O (1:500), Trasylol, 2.8 mg/ml in H2O (1:500)] 
2.2.2.7.3. Purification of GST fusion protein using glutathione sepharose beads 
The GST fusion proteins were purified using the glutathione sepharose beads which have 
specific binding affinity to Glutathione S-transferase linked to the protein. The cells 
collected from 1litre of main culture were dissolved in 20 ml of 1× PBS (140mM NaCl, 
2.7 mM KCl, 10mM Na2HPO4, 1.8mM KH2PO4 (pH 7.4) with fresh protease inhibitors, β 
mercaptoethanol and 1 mg/ml lysozyme). The cells were subjected to ultrasonication for 
30 seconds (5×) with 1 minute break in between the cycles.  The cell debris was collected 
by centrifugation at 15000 rpm for 30 minutes at 4°C. Two ml of glutathion sepharose 4 
super flow (Amersham Biosciences) was equilibrated in 1× PBS, the cell lysate 
supernatant was added to the beads and incubated in a shaker at 4°C. The beads were 
washed thrice with 1× PBS containing fresh protease inhibitors. The protein was eluted in 
5× 1 ml fractions of elution buffer (50mM Tris-HCl pH 8.0, 10mM reduced glutathione). 
The fractions were then processed as described above (2.2.2.7.2). 
2.2.2.7.4. Concentration and lyophilization of purified proteins 
Protein concentration was estimated by methods described above (2.2.2.1.), the solution 
was concentrated using the Millipore protein concentrator’s with 10kDa molecular 
weight cut off if necessary or the protein solution was diluted to obtain a final 
concentration of 1 mg/ml, lyophilized and stored at -80°C. 
2.2.2.8. Sucrose-loaded large unilamellar vesicle (SLV) pull down assay 
Sucrose-loaded large unilamellar vesicles (SLVs) were generated using a mini-extruder 
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(Avanti Polar Lipids, Inc.) according to manufacturer’s instructions, mixed with Vt 
protein and sedimented. In brief, vesicles containing phospholipids PC, PS (45%) 
(Sigma), and PIP2 (7%) (Merck Biosciences) from bovine brain, in molar ratios 
4.8:4.5:0.7, were prepared by solubilizing dried phospholipid films (dried using nitrogen 
gas) in buffer 1 (600 mM sucrose, 100 mM NaCl, 40 mM Tris-HCl pH 7.5 and 3 mM 
MgCl2).Vesicles were subjected to repeated freeze-thaw cycles (5 times) and thereafter to 
extrusion (11 times) using 0.2 µm filters in a mini-extruder. Vesicle suspension was 
diluted 1:5 in buffer 2 (100 mM NaCl, 40 mM Tris-HCl pH 7.5, 3 mM MgCl2) and 
vesicles were collected by high-speed centrifugation, 100000×g for 30 minutes in an 
airfuge (Beckman Instruments). Vesicles were washed again and finally suspended in 
buffer 2 (1 mg/ml total lipid). Proteins were diluted in buffer 2 (5 µM protein, final 
concentration), pre-centrifuged at 20000×g for 15 minutes to remove any protein 
aggregates and incubated with SLVs (0.5 mg/ml final concentration) at 37°C for 15 
minutes. After incubation, protein-vesicle mixtures were centrifuged at 20000×g for 15 
minutes. Pellet and supernatant fractions were separated and proteins retrieved from 
supernatants by methanol /chloroform precipitation (Wessel and Flügge, 1984). Pellet 
and supernatant were subjected to SDS-PAGE and Coomassie stained bands analysed by 
densitometry (E.A.S.Y. RH apparatus and E.A.S.Y. Image plus Software; Herolab, Inc.). 
Statistical significance of differences in all data sets (unless stated otherwise) was tested 
by variance analysis (post hoc Bonferroni/Dunn) using Statview 5.0 ® (SAS Institute, 
Inc.). 
2.2.2.9. “High speed” actin cosedimentation assay 
The interaction of Vt variants with actin filaments was tested by high-speed 
cosedimentation at various molar ratios of actin and vinculin tail. Pre-polymerization of 
actin was performed by diluting actin in pre-polymerization buffer (20 mM Tris pH 7.4, 
100 mM KCl, 2 mM MgCl2 with freshly added 1 mM ATP and 0.2 mM DTT) and one 
hour incubation at 37°C. Pre-polymerized actin was used at 3µM final concentration in 
the assay. Varying concentrations of Vt (0.6 – 3 µM) diluted in F-actin buffer (20 mM 
Tris pH 7.4, 25 mM KCl, 2 mM MgCl2 with freshly added 1 mM ATP and 0.2 mM DTT) 
were incubated with pre-polymerized actin for one hour in a 37°C shaker. The reaction 
mixture was centrifuged at 100000×g for one hour in an airfuge (Beckman Instruments). 
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Pellets and supernatants were analysed by densitometry of Coomassie stained gels as 
described above (2.2.2.8.).  
2.2.2.10. GST pull down assay for vinculin head –vinculin tail interaction 
The interaction of Vt variants with the Vinculin head domain (D1, amino acids 1-258) 
fragment was tested in a GST pulldown assay. GST-Vh (D1) protein bound to glutathione 
sepharose beads was equilibrated in phosphate buffer (50 mM NaH2PO4, 0.2 mM EGTA) 
and incubated with Vt proteins (6 µM) for 30 minutes at 37°C. Beads were then washed 
three times with buffer. Pellet fractions were analysed on Coomassie stained SDS-PAGE 
gels.  
2.2.3. Cell biological methods 
2.2.3.1. Cultivation of cells  
All the cell culture media and additives were purchased from Gibco BRL and Sigma. 
The composition of culture medium used to cultivate the different cell lines are listed 
below. 
B16-F1 medium: B16-F1 mouse melanoma cells (ATCC CRL-6323) were grown in 
DMEM, 4.5 g/l glucose (Invitrogen, Germany) with 10 % FCS (PAA Laboratories, 
Austria) and 2mM glutamine at 37°C and 7 % CO2. Penicillin/Streptomycin was used in 
the medium if needed. 
G418 (1 mg/ml) was used in the medium to cultivate the stable cell populations 
expressing GFP vinculin wild type and mutants. 
NIH 3T3 medium: NIH 3T3 murine embryonic fibroblasts (ATCC CRL-1658) were 
maintained as above but with 10 % FBS (Sigma, Germany).  
C2C12 medium: C2C12 mouse myoblasts (ATCC CRL-1772) were cultured in DMEM, 
4.5 g/l glucose (PAA Laboratories, Austria) with 10% FCS (PAA Laboratories, Austria) 
at 37°C and 10 % CO2.  
MEF medium: The vinculin null fibroblasts MEF -/- were grown in DMEM, 4.5 g/l 
glucose (PAA Laboratories, Austria) with 10 % FCS (PAA Laboratories, Austria), 5 µl  
β-mercaptoethanol at 37°C and 10 % CO2.  The control fibroblasts MEF+/+ were 
cultivated as above without β-mercaptoethanol. 
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2.2.3.2. Transient transfection of cells 
Transfections were carried out with SuperFect (Qiagen)for B16-F1 or with FuGENE6 
(Roche) for NIH 3T3, C2C12, MEF’s  according to manufacturers’ protocols. 
In brief, 1 µg DNA was mixed with 300 mL of DMEM, to which 6 µL of SuperFect were 
added and vortexed immediately for 10 seconds. The reaction was left for 20 to 40 
minutes at room temperature. 1.8 ml of growth medium was added to the reaction mix 
and the complete mix was added onto cells in a 3.5 cm diameter dish or 0.5 ml to a well 
in 12 well plates.  
47µl DMEM were mixed with 3µl FuGENE6 and 1µg plasmid DNA and incubated for 
30 minutes at room temperature. The mixture was added to cells in a 3.5 cm diameter 
dish with freshly replaced media and incubated at 37°C. The mixture was scaled-up 
accordingly for 10 cm plates or increased number of cells. 
2.2.3.3. Generation of stable B16-F1 populations expressing GFP vinculin constructs using 
FACS  
B16-F1 cells were transfected with GFP vinculin wild type and mutants and the cells 
were allowed to express the protein for 12 – 16 hours. The cells were then trypsinized 
and sorted with a fluorescence associated cell sorter (Cytomation Inc, USA). The sorted 
cells were cultivated in the presence of G418 (1 mg/ml) selection pressure for a week to 
10 days. The cells were subjected to a second round of sorting and grown under the 
selection pressure and several aliquots were frozen for future use. 
2.2.3.3.1. Protein expression levels in the B16-F1 stable cell populations 
The expression levels of GFP vinculin wild type and variants in different passages (1-5) 
were analysed in a semi-quantitative Western blot of the cell lysates prepared by lysis of 
cells in one confluent 10 cm plate with 300-400 µl of 4× SDS sample buffer (2%SDS, 
350mM Tris HCl pH 6.8, 10% Glycerin, 8% β-mercaptoethanol, 0.05% Bromophenol 
blue). The blots were stained using vinculin antibody (hvin) which detects both 
endogenous vinculin (116kDa) and the exogenous GFP vinculin (~ 141kDa). The blots 
were subjected to densitometric analysis to determine the total vinculin and ratios 
between endogenous and recombinant vinculin expression levels. 
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2.2.3.4. Culture of cells on coverslips for microscopic analysis 
For microscopic analyses, cells were seeded onto 12 mm or 15 mm glass cover slips that 
had been pre treated in a mixture of 60% ethanol and 40% concentrated HCl for 30 
minutes to 3 hours in a shaker. Coverslips were then extensively washed in water and 
allowed to dry separately on Whatman filterpaper overnight and were sterilized by 
autoclaving or by exposure to UV-light for 45 minutes. Glass coverslips were coated with 
50 µg/ml fibronectin (Roche) for 1 to 2 hours at room temperature or overnight at 4°C or 
25 µg/ml laminin (Sigma) for 50-60 minutes at room temperature as indicated. 
2.2.3.5. Fixation procedures and permeabilization of cells 
For immunostaining, cells were fixed with 4% para formaldehyde (PFA) in PBS for 5 – 
10 minutes. Cells were then extracted with a mixture of 0.1% Triton X-100 and PFA for 
45 seconds for B16-F1 cells and 5-7 minutes for C2C12, NIH 3T3 and MEF’s. The cells 
were thoroughly washed thrice with 1× PBS and stored at 4°C until they were stained.  
2.2.3.6. Immunolabelling, fluorescence microscopy and image processing 
To avoid non-specific interactions, cells were blocked prior to antibody staining with 1% 
BSA in PBS for 20 minutes. For antibody staining, coverslips were incubated with 50 µl 
of primary antibody solution on parafilm for 1-2 hours at room temperature or 45 min at 
37°C in a humid chamber, followed by 3 washes in 1× PBS. Staining with secondary 
antibody with or without addition of fluorescently coupled phalloidin was carried out for 
30 – 45 minutes at 37°C in a humid chamber.  Coverslips were mounted in 5 µl Mowiol 
4-88 (Calbiochem) supplemented with n-propylgalate (2.5 µg/ml) on microscope glass 
slides, dried and stored in the dark at 4°C until analysis. 
Cells were observed on an inverted microscope (Axiovert 135TV, Zeiss) equipped for 
epifluorescence and phase-contrast microscopy, using 100x NA 1.3 neofluar objective, as 
well as 63x and 40x.NA 1.3 neofluar objectives, with 1.6 optovar intermediate 
magnification. Electronic shutters (e.g. Uniblitz Electronic 35mm shutter including driver 
Model VMMD-1, BFI Optilas) to allow computer-controlled opening of the light paths 
were attached to the microscope and a filterwheel (e.g. LUDL Electronic Products LTD, 
SN: 102691 and driver SN: 1029595) to enable two-colour epi-fluorescence in 
combination with appropriate dichroic beam splitters and emission filters (Chroma 
Technology Corp., Rockingham, USA). Tungsten lamp (Osram, HLX64625, FCR 12V, 
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100W) was used for phase contrast optics and mercury lamp (HBO 100W/2, Osram) for 
epifluorescence. The immersion oil (refraction index of 1.5) was obtained from Zeiss 
Data were acquired with a back-illuminated, cooled charge-coupled-device (CCD) 
camera (Princeton Research Instruments TKB 1000x800, SN: J019820; Controller SN: 
J0198609) driven by IPLab software (Scanalytics Inc.). Data were stored as 16-bit digital 
images and analysed on a Power Macintosh G4 using IPLab, Scion Image 1.62 (Scion) or 
Adobe Photoshop 6.0 software. 
Alternatively the cells were examined in a Zeiss Axiovert S100TV microscope using a 
100x Plan-Neofluar oil objective (NA 1.3) or 63x Plan-Neofluar oil objective (NA 1.25) 
and photographed with a TE/CCD-1000 TKB camera (Princeton Scientific Instruments). 
Images were acquired and processed using MetaMorph software (Universal Imaging 
Corporation) followed by Adobe Photoshop 6.0 software. 
2.2.3.7. Migration assay in 3D collagen matrix 
The migratory capacity of the B16-F1 populations expressing GFP-vinculin variants on 
3D collagen matrix was analysed by timelapse video microscopy as described 
(Niggemann et al., 1997). In brief, cells were harvested in trypsin-EDTA, and 6 x 104 
cells in 50 µl medium were mixed with 100 µl of a carbonate-buffered collagen solution 
(1.67 mg/ml bovine dermal type I collagen, commercially available as vitrogen from 
Cohesion Technologies, Inc). 
The suspension was filled into self-constructed chambers and the collagen was allowed to 
polymerize at 37°C for 30 minutes. Migration of the cells was recorded for 15 hours in a 
1920 fold timelapse mode (one hour equalent to 1920 hours). The paths of 30 randomly 
selected cells were calculated in 15 minutes step intervals by computer-assisted cell 
tracking using custom-made software (Niggemann et al., 1997) and migratory parameters 
(number of motile cells, velocity, persistence) were calculated from these data. 
2.2.3.8. Live cell imaging of B16-F1 stable populations 
The microscope Axiovert 135TV, Zeiss was employed as described in section 2.2.3.6. 
Due to high probability photo-damage and bleaching by mercury lamps, for the live cell 
imaging a tungsten lamp was employed for epifluorescence and transmitted illumination. 
Cells were observed in an open chamber (Warner Instruments, Reading, UK) with a 
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heater controller (model TC-324B, SN: 1176) at 37°C. Ham’s F12 HEPES-buffered 
medium (Sigma) including complete supplements of the regular growth medium (see 
2.2.3.1.) was used for B16-F1 cells. During live imaging, the medium was changed every 
30 minutes. 
2.2.3.9. Adhesion and Spreading assay 
Twelve well plates (Nunc) were coated with either laminin (25 µg/ml) or fibronectin (50 
µg/ml) (Sigma) and incubated at room temperature for 1 hour. Alternatively, they were 
coated with collagen I (1 mg/ml; Cohesion Technologies, Inc.) and allowed to polymerise 
for 3 hours. B16-F1 cells expressing GFP-vinculin variants were harvested in trypsin-
EDTA. 1.5 x 104 cells were seeded to each well.  
For analysis of adhesion, cells were allowed to attach for 10 minutes at 37°C on laminin 
and fibronectin or 90 minutes on collagen. Non-adherent was removed by washing wells 
three times with PBS. Cells were fixed in 4% PFA in PBS. Number of cells in 10 random 
microscopic fields (450-550 cells) was counted using a Nikon Eclipse TE 300 with a 10x 
Plan-Fluar objective (NA 0.3).  
For analysis of spreading, cells were treated as described above and allowed to attach for 
15 minutes at 37°C on laminin or fibronectin. After washing and fixation, cells were 
stained with TRITC-Phalloidin (Sigma) and mounted on slides. Cells were examined in a 
Zeiss Axiophot microscope using a 40x Plan Neo-Fluar oil objective (NA 1.3) and 
photographed with a RTE/CCD – 1300 Y/HS camera (Roper Scientific). Three sub-
populations of cells were counted, spread cells with clear peripheral lamellipodia, non-
spread cells, which were just attached, and ambiguous cells that fell in neither of the two 
categories. 
2.2.3.10. Fluorescence recovery after photo bleaching (FRAP) 
B16-F1 cells were microinjected (InjectMan NI 2; Eppendorf) with constructs encoding 
GFP-vinculin-wt or the LD mutant. Constructs were allowed to express for 3 hours 
before mounting coverslips into a chamber containing gassed growth medium. The 
chamber was placed on a temperature-regulated 37°C microscope stage 15 minutes 
before viewing. Time-separated confocal 12-bit images were collected using a Zeiss LSM 
510 META confocal laser scanning microscope system with a 63x Plan-Apochromat oil 
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objective (NA 1.4). GFP was excited with the 488 nm line of the Argon laser and 
reflected and emitted light separated using a 470-500 nm bandpass filter (for interference 
reflection microscopy) and a 505 nm longpass filter (for viewing GFP emission). 
Linescans were performed with four-fold averaging per pixel. When bleaching, the 488 
nm laser line output was set to 100 % using 50 iterations. Two images (lines) were 
scanned prior to bleaching to determine the pre-bleach intensity of GFP-vinculin. After 
bleaching, linescans were collected for 3 minutes and stacked together to form a 2D 
image using the Lucida Image Analysis package (Kinetic Imaging, Inc.), a so-called 
kymograph, where the x-axis is distance along the linescan, and the y-axis represents 
time with t=0 at the top (Courtesy: Dr. Mark R.Holt). 
2.2.3.11. Retrograde sliding of focal adhesions  
To determine speed of focal adhesion translocation, adhesions in timelapse sequences 
were manually tracked using the Motion Analysis package (Kinetic Imaging, Inc). The 
software calculated the speeds after appropriate calibration. Fluorescence recovery in 
timelapse FRAP sequences was analysed using the Lucida Image Analysis package 
(Kinetic Imaging, Inc). Since focal adhesions had a tendency to translocate, it was not 
possible to perform a simple spot analysis. Instead, kymographs were produced along the 
axis of the adhesion sites and the direction of translocation. Five linescans were then 
taken along the kymograph time axis taking into account any translocation. The average 
of this was normalized with respect to the initial fluorescence intensity. Normalized 
values were subtracted using the first post-bleach intensity, which also resulted in 
background subtraction. 
The data were then inversely plotted to produce a straight-line graph with positive 
gradient. The x-intercept was used to determine the time constant for fluorescence 
recovery, i.e., the time taken to recover to a level of 50%. Statistics of data in this 
paragraph were performed applying an unpaired two-tailed t test (with Welch correction) 
using InStat3 ® (GraphPad Software, Inc.) (Courtesy: Dr. Mark R.Holt). 
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3. Results 
3.1. Design and cloning of various recombinant protein constructs 
3.1.1. Cloning of full length vinculin and vinculin tail domains 
The structural and functional role of vinculin in the regulation of adhesion sites was 
studied using recombinant protein constructs. Prokaryotic and eukaryotic expression 
constructs were employed for biochemical and cellular characterization of the protein. To 
analyse the involvement of acidic phospholipids (PIP2) in the regulation of vinculin, 
expression constructs harbouring mutations in the putative lipid binding sites were 
generated by site directed mutagenesis. 
The full length “wild type” vinculin clone comprising the amino acid sequences 1-1066 
was derived from a cDNA clone provided by Dr. Stefan Hüttelmaier. Sequencing 
analysis of this clone identified several mutations which were reverted back by site 
directed mutagenesis (Refer to chapter 2.2.1.10.). The “wild type” tail domain construct 
comprising the amino acid sequences 858-1066 was generated by PCR amplication of 
full length vinculin. (Refer to chapter 2.2.1.10.).  
The crystal structure of vinculin tail describes the stretch of arginines and lysines in the 
basic collar and basic ladder to be the putative PIP2 binding motifs (Bakolista et al; 
1999). These arginines and lysines were the potential candidates for the target mutations 
to obtain a lipid binding deficient vinculin mutant. Three different mutant tail domains 
carrying point mutations in the PIP2 binding motifs were constructed by site directed 
mutagenesis in the Vt wild type. The mutant carrying point mutations in the C-terminus 
(basic collar), which had two amino acids exchanged to glutamine (RK 1060/61 to QQ) 
was named as the CT mutant (Vt-CT), another mutant carried the point mutations in the 
Helix3 (basic ladder), which had four amino acids exchanged to glutamine (KK 952/956 
to QQ and RK 963/966 to QQ) was named as the H-3 mutant (Vt-H-3). The third mutant 
carried the combination of both CT and H-3 mutations and was named as the LD (Lipid 
binding Deficient) mutant (Vt-LD) which had totally six amino acids exchanged to 
glutamine (Figure 3.1). In addition to all the above mutants, a C-terminal deletion 
construct, similar to one described earlier (Bakolista et al; 1999), named as ∆1052, 
lacking the final 14 amino acids was also constructed to serve as an internal control for 
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the biochemical characterization of the Vt domains. In the full length “wild type” 
vinculin construct, the mutant tail domains were exchanged against the wild type domain 
using appropriate restriction endonuclease digestion, which allowed easier subcloning of 
the mutants into full length vinculin (also see cloning strategy in chapter 2.2.1.10.) 
Vinculin tail (Vt 858-1066) wild type and mutants were cloned in the prokaryotic expression 
vector pQE 30 for protein expression and employed in the biochemical characterization. 
Full length vinculin constructs cloned in the GFP fusion vector pEGFP-C2 were used for 
cellular expression and phenotypic characterization. 
 
 
Figure 3.1: Schematic representation of wild type and mutant tail domains. 
A) Vt -wt representing the conserved sequences coding for the lysines and arginines 
(K/R) in the CT and H-3 lipid binding sites.  
B) Mutant Vt -CT sequences with lysine and arginine (R1060/K1061) both exchanged to 
glutamine (Q). Altered sequences are shown in red. 
C) Mutant Vt -H-3 sequences with one arginine (R963) and three lysines 
(K952/K956/K966) exchanged to glutamine (Q). Altered sequences are shown in red. 
D) Mutant Vt -LD with the combination of both CT and H-3 mutations. Altered 
sequences are shown in red.  
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3.1.2. Cloning of vinculin head domain (D1) 
Vinculin head domain (D1), the N-terminal 258 amino acids comprising the vinculin tail 
and talin binding sites was amplified by PCR and cloned into pGex 4T-1, a GST fusion 
vector, for protein expression and biochemical analysis (Refer to chapter 2.2.1.11.). 
3.1.3. Cloning of mouse PIP 5-kinase α “kinase dead” (KD) mutant 
Murine PIP 5-kinase α  clone (Rozelle et al, 2000) was used to generate the “kinase 
dead” form of PIP5-kinase α (1-308 amino acids), a C-terminal deletion construct created 
by PCR amplification, fused to BiPro tag (Rudiger et al, 1997) for antibody recognition 
and subcloned into the eukaryotic expression vector pcDNA3. 
3.2. Protein properties and surface model of the mutant vinculin tail domains 
Protein properties of the Vt wildtype and mutants were predicted using the Laser gene 
navigator software. The software calculated the molecular weight, isoelectric point, 
changes in secondary structure (helical wheel representation) which could help in 
differentiating the wild type from the mutants. Loss of positively charged residues was 
implicated by a decrease in pI of the tail domains (Table 3.1.). Graphic views of solvent – 
accessible surfaces of Vt 879-1061 wild type and Vt 879-1061  LD indicate the difference in 
electrostatic potential as a consequence of the amino acid exchanges, basic patches (blue) 
are changed to acidic (red) or neutral (white) around the basic collar and basic ladder 
(Figure 3.2. ) 
 
                 Table 3.1: Isoelectric points of vinculin tail domains 
Vt Domains Isoelectric point 
Wildtype 8.54 
CT 7.90 
H-3 7.06 
LD 6.54 
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Figure 3.2: Surface models of Vt 879-1061 wild type and LD 
Solvent-accessible surfaces of Vt 879-1061 wild type (A) and Vt 879-1061 LD (B). Coloring 
reflects the electrostatic potential, basic patches in blue and acidic in red. The two lipid 
binding sites, basic collar and basic ladder, are indicated by dotted lines. In Vt 879-1061 LD 
(B) The areas carrying point mutation of the C-terminus (CT) and helix 3 (H-3) are 
circled. (Courtesy: Dr. Jochen Kuper) 
3.3. Protein expression and purification  
Vinculin tail domains (wild type and mutants) were expressed from pQE 30, a 
prokaryotic expression vector with 6X His tag for recombinant protein expression and 
affinity purification using Ni-NTA agarose. These constructs also had N-terminal 
sequences coding for a “Flag epitope” which could be recognized by flag antibody (M2) 
for easier detection in Western blot. The His tagged fusion proteins were expressed in the 
M15 strain of E. coli and purified using Ni-NTA agarose as described in section 2.2.2.7. 
The purified proteins were analysed on SDS-PAGE and also by Western blot using a flag 
antibody (M2).  
The vinculin head domain (D1) was expressed from pGEX 4T-1, for expression of a GST 
fusion protein in the M15 strain of E. coli and purified using glutathione-sepharose beads. 
The purified protein was analysed by SDS-PAGE and Western blot using a GST antibody 
(also see chapter 2.2.2.7.). 
The protein concentration was estimated using the BCA method (Chapter 2.2.2.1.2.) and 
diluted to a final concentration of 1 mg/ml in phosphate buffer (50mM NaH2PO4, 0.2mM 
EGTA, pH 7.4), lyophilized and stored at -80° C. 
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Table 3.2: List of vinculin tail domain and vinculin head domain constructs 
    
     Construct 
   
     Amino acids 
            
           Tag 
Mol.Wt Calculated 
(apparent) in kDa 
Vt wt 858 – 1066 His, Flag (N-terminal) 25.9 (~30) 
Vt CT 858 – 1066 His, Flag (N-terminal) 25.8 (~30) 
Vt H-3 858 – 1066 His, Flag (N-terminal) 25.8 (~30) 
Vt LD 858 – 1066 His, Flag (N-terminal) 25.8 (~30) 
Vt ∆ 1052 858 – 1052 His, Flag (N-terminal) 24.0 (~29) 
Vh D1 1 - 258 GST 58.8 (~62) 
  
3.4. CD spectroscopic analysis of Vt domains 
Circular Dichroism (CD) is observed when an optically active matter absorbs left and 
right hand polarized light differently, the difference in the absorption is very small 
corresponding to the ellipticity of 1/100th of a degree which is measured by a CD 
spectropolarimeter. CD Spectroscopy is a method to analyse the basic secondary structure 
of a polypeptide chain or protein, since the absorption spectra for each type of secondary 
structure, (α helix, β pleated, coils) are different. Recombinant proteins are analysed by 
CD spectroscopy to confirm the proper folding of the protein and that the secondary 
structure is preserved. CD spectra were processed using the “Spectra Analyzer” and 
“DicroProt” software (Jasco Systems) which calculates the molar ellipticity and 
percentage composition of α helices, β sheets and coiled-coils in each molecule.  
The CD spectra of Vt wild type and LD in the far UV region showed absorption minima 
at 208 nm and 226 nm approximately which was typical for protein with an α helical 
structure. CD spectra of vinculin LD confirmed the maintenance of the secondary 
structure and proper folding of the protein (Figure 3.3.). 
 
                                                                                                                        3. Results 44
-20
-10
0
10
20
30
40
190 200 210 220 230 240 250
Wavelength (nm)
∆ε
 (c
m
-1
 M
-1
)
vt-LD
vt-wt
 
Figure 3.3: CD Spectroscopic analysis of Vt domains 
CD Spectra of Vt wild type and Vt LD in the far UV region showing absorption minima 
at approximately 208 nm and 226 nm  
 
I. Biochemical analyses 
3.5. Biochemical characterization of Vt wild type and mutants 
The purified vinculin tail domains were subjected to various biochemical analyses to 
investigate their ability to bind acidic phospholipids, to co-sediment with actin and to 
confirm intact intramolecular head-tail interaction. All these assays were aimed towards 
the analysis and comparison of Vt wild type and mutant proteins. 
3.5.1. Effect of the Vt mutations on the binding affinity to acidic phospholipids  
Binding to acidic phospholipids such as PIP2 is considered a critical step in the activation 
of cytoplasmic vinculin, leading to its interaction with protein ligands (Hüttelmaier et al; 
1998) and subsequent targeting of vinculin to focal adhesions (Gilmore and Burridge, 
1996).  The lipid binding characteristics of Vt wild type and all three mutants were tested 
in a pull down assay, using sucrose-loaded large unilamellar vesicles (SLVs).  Vesicles 
were generated in a mini-extruder (Avanti polar lipids Inc, USA) and contained 
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phosphatidylcholine (PC) and acidic phospholipids phosphatidylserine (PS) and PIP2 in 
the ratio of 4.5: 4.5: 1. This composition was selected to mimic lipid conditions at the 
inner leaflet of the plasma membrane and also to avoid electrostatic sequestration as a 
result of highly negatively charged surfaces, which are characteristic for pure PIP2 
micelles or PS vesicles. Pure PC vesicles were used as a control.  The lipid vesicles were 
incubated with Vt proteins and sedimented. Vt protein in the pellet (that is bound to 
vesicles) and in the supernatant (unbound) were detected in Coomassie-stained gels and 
analysed by densitometry (refer to section 2.2.2.8.). Binding of the Vt wild type to 
vesicles was compared to Vt-∆1052, which was earlier reported to display a reduced 
binding to phospholipids (Bakolitsa et al, 1999) and to other mutant tail domains. Vt 
mutants Vt-∆1052, Vt-CT and Vt-H3, which all have one lipid binding site altered, 
showed partial loss of lipid binding (<50% compared to wt) (Figure 3.4.). Mutations of 
both the lipid binding sites in Vt-LD resulted in residual binding, comparable to the 
binding obtained for all Vt proteins when using control PC vesicles  
(8-10%, white line). The combination of mutations hence abolished the binding of Vt-LD 
to acidic phospholipids. (Figure 3.4.)  Differences in binding were observed in three 
independent experiments and confirmed by variance analysis (p<0.05; Bonferroni/ Dunn, 
Statview 5.0, 1998). 
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Figure 3.4: SLV pull down assay with Vt wild type and mutants 
Top: Coomassie-stained gel with pellet (P) and supernatant (S) fractions of Vt wild type 
and other mutants.  
Bottom: The columns represent the percentage of vesicle-bound Vt protein (mean ± s.e; 
n=3). Binding of mutant tails to acidic phospholipids is decreased compared to wild type. 
The white line indicates the binding to control PC vesicles. 
3.5.2. Binding to filamentous actin is preserved in the Vt mutant proteins 
F-actin is one of the major ligands that bind to the vinculin tail, whose binding is 
influenced by the intra molecular head-tail interaction and also by the acidic phospholipid 
PIP2 (Hüttelmaier et al, 1998, Johnson and Craig, 1995). In order to analyse the 
consequence of the mutations in the vinculin tail on its actin binding, the proteins were 
subjected to a high speed co-sedimentation assay using pre-polymerized actin. Vt 
proteins were incubated with pre-polymerized actin and sedimented at high speed 
(100000×g). Pellet and supernatant fractions were subjected to SDS PAGE, stained and 
analysed by densitometry. The assay was performed using two different molar ratios of 
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actin:vinculin, 5:1 (Fig 3.5A) and 2:1 (Fig. 3.5B). Cosedimentation of vinculin tail 
proteins with F-actin at molar ratio of actin: vinculin = 5:1 was > 95% for the wild type 
and all mutants, suggesting that actin binding is preserved in all the mutants. 
At a molar ratio of actin: vinculin = 2:1, the binding of both Vt-H-3 and Vt-LD was 
decreased by 35% as compared to Vt wild type and Vt-CT. This ratio represents maximal 
binding capacity of F-actin which is 0.3 – 0.5 moles of vinculin tail per mole of actin. 
(Johnson et al; 1995) and is not considered physiologically relevant (also refer to chapter 
4.2. for details). 
 A                                                    B 
                
                                                       
                                                C 
                                            
Figure 3.5: Interaction of Vt wild type and mutants with filamentous actin 
Pellet (P) and supernatant (S) fractions obtained from cosedimentation assays at  
(A) 5:1 molar ratio of actin:vinculin, (B) 2:1 molar ratio of actin:vinculin, detected on 
Coomassie-stained gels. (C) Columns represent the percentage of Vt protein bound to  
F-actin at molar ratio 2:1 (mean ± s.e; n=3). Vt mutants H-3 and LD show decreased 
binding at this molar ratio. 
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3.5.3. Interaction of Vt proteins with GST-Vh (D1)  
Intra molecular head – tail interaction in vinculin is critical for activation of the protein 
(Hüttelmaier et al, 1998, Johnson and Craig, 1995). It influences the ligand binding 
properties by blocking the various binding sites in the head, rod and tail domains. The 
vinculin tail mutations were designed so as to preserve the head-tail interaction.  
Interaction of Vt proteins were determined in a pull down assay using the GST-Vh (D1) 
fusion protein bound to Glutathione-sepharose beads. The sedimented Vt proteins were 
densitometrically analysed on a Coomassie-stained gel and the head to tail interaction 
was found intact for all tested constructs (Figure 3.6). 
 
Figure 3.6: GST pull down assay for Vh – Vt interaction 
Coomassie-stained gel showing the bound Vt proteins (wt and mutants) to GST Vh (D1) 
bound to glutathione sepharose beads. 
 
II. Cell biological analyses 
3.6. Cellular expression and phenotypic characterization of full length vinculin GFP 
fusion proteins 
Full length vinculin wild type and lipid binding deficient mutants were fused to GFP in 
the pEGFP-C2 vector and used to analyse the localization in focal adhesions and the 
effect of the mutations on the functional regulation of vinculin in the adhesion sites 
during cell migration and adhesion. These experiments were designed to provide deeper 
insight into the regulation of the protein, mediated through PIP2 at the FAs. 
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3.6.1. Stable expression of GFP-vinculin constructs in B16-F1 mouse melanoma cells 
B16-F1 mouse melanoma cells were chosen for expression of GFP vinculin constructs. 
Due to their high motility rates on certain extracellular matrices, analyses of cell motility 
and adhesion turn over were greatly facilitated. B16-F1 cells were transfected with full-
length wildtype and mutant GFP-vinculin variants, and populations of cells stably 
expressing the respective constructs were obtained by a combination of FACS sorting and 
antibiotic (G418) selection (see chapter 2.2.3.3.). Expression of GFP-vinculin in these 
populations was stable for more than six passages. These cells were used for a set of 
experiments to differentiate wt from the mutants based on protein localization, cell 
adhesion and migration. Protein expression patterns were determined by semiquantitative 
Western blotting of cell lysates from parental B16-F1 and transfected populations at 
different passages (1-5). A vinculin antibody (hvin) was used to detect endogenous 
vinculin and GFP fusion proteins (Figure 3.7.). Comparison of the levels of vinculin as 
determined by Western blot revealed the ratios of ectopic to endogenous protein varying 
from 0.3 – 0.45 of total vinculin (Figure 3.7.). Although fusion protein expression was 
under the control of a CMV promotor which allows overexpression of the protein, 
absolute amounts of vinculin in transfected cells never exceeded 150% of total vinculin 
in parental B16-F1 cells, indicating a regulation of endogenous protein levels. 
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Figure 3.7: Protein expression pattern in B16-F1 stable cell populations 
 A) Western blot with vinculin antibody (hvin) showing endogenous (117 kDa) and GFP 
fused vinculin (~141 kDa) from parental cells and cells expressing GFP-vinculin variants. 
 B) Columns represent levels of GFP vinculin in the stable populations expressed as 
percentage of total vinculin. 
3.6.2. Localization of full length GFP vinculin constructs in various cell types 
PIP2 mediated activation of vinculin is considered to be important for its ligand 
interactions and focal adhesion localization (Gilmore and Burridge, 1996). Therefore, 
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localization studies with GFP vinculin variants were essential to yield more details on the 
role of PIP2 in activation and adhesion site targeting of vinculin. 
The localization studies were carried out in B16-F1 mouse melanoma cells, C2C12 
mouse myoblasts and NIH 3T3 mouse fibroblasts. Mouse embryonic fibroblasts from 
vinculin null mice were also used to study the localization pattern, without endogenous 
protein background, which could influence the activation of vinculin variants due to 
formation of tail hetero-oligomers. 
B16-F1 cells transfected with GFP vinculin wild type and mutants were seeded onto 
laminin coated coverslips and fixed after six hours. Cells were then counterstained with 
paxillin antibody and phalloidin to visualize focal adhesions and actin filaments 
respectively. Wild type GFP-vinculin as well as all lipid-binding mutants localized to 
focal adhesions and perfectly colocalized with paxillin and the ends of actin filament 
bundles. The population of B16-F1 cells expressing GFP-vinculin-LD displayed a high 
number of cells with abnormally long adhesive extensions, cells contained more 
pronounced stress fibres and larger focal adhesions as compared to populations 
expressing other vinculin variants (Figure 3.8.). 
C2C12 and NIH 3T3 cells were seeded on fibronectin coated coverslips, transfected with 
GFP vinculin constructs and fixed after twelve hours. Cells were stained to visualize actin 
filaments with phalloidin or endogenous vinculin with vinculin antibody. Both GFP 
vinculin wild type and LD were localized in the focal adhesions. (Figure 3.9.). 
Embryonic fibroblasts from vinculin null (MEF-/-) and control mice (MEF+/+) were 
seeded on glass coverslips, transfected with GFP vinculin constructs and fixed after 12 – 
16 hours. There were no differences in the localization of GFP vinculin wt and LD in the 
vinculin null cells and the control fibroblasts (Figure 3.11.). MEF-/- and MEF+/+ cells 
were also stained with vinculin antibody to detect the presence of endogenous vinculin 
(Figure 3.10). 
Localization of GFP-vinculin LD at the adhesion sites in the null cells indicated that PIP2 
mediated regulation is not essential for focal adhesion targeting of vinculin.  
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Figure 3.8: Localization of GFP – vinculin variants in B16-F1 cells 
B16-F1 cells transfected with GFP-vinculin constructs were seeded on laminin and 
allowed to attach for six hours. Cells were fixed and stained for paxillin and the actin 
cytoskeleton. Localization of GFP-vinculin constructs, paxillin and F-actin in exemplary 
cells are shown individually (grey scale) as well as on merged images of GFP- vinculin 
(green), paxillin (blue), F-actin (red) and enlargements of the regions indicated. Bars: 10 
µm and 2 µm, respectively. 
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Figure 3.9:  Localization of GFP vinculin variants in C2C12 and NIH 3T3 cells 
C2C12 and NIH 3T3 cells were seeded on fibronectin and transfected with GFP vinculin 
constructs. C2C12 cells expressing GFP vinculin wild type (A) and LD-GFP vinculin 
(B). NIH 3T3 cells expressing wild type GFP vinculin (C) and LD-GFP vinculin (D). 
Both constructs were localized in focal adhesions (arrow heads). Bar: 10 µm 
 
 
 
                        
 
Figure 3.10: Staining for endogenous vinculin in MEF -/- and MEF +/+ cells 
MEF -/- vinculin (A and B) and MEF +/+ vinculin (C and D) stained for endogenous 
vinculin with vinculin antibody and the corresponding phase contrast images. Vinculin 
null cells (A) lack vinculin staining, while the control cells show endogenous vinculin in 
focal adhesions (B).Bar: 10 µm 
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Figure 3.11.: Localization of GFP vinculin variants in vinculin null and control 
mouse embryonic fibroblasts  
MEF -/- vinculin (A and B) expressing GFP vinculin wild type (A) and vinculin LD (B) 
and MEF +/+ vinculin (C and D) expressing GFP vinculin wild type (C) and vinculin LD 
(D). Both constructs were targeted to the adhesion sites (arrow heads). Bar: 10 µm 
3.6.3. Migration of cells expressing GFP vinculin variants on 3D collagen matrix 
The effect of lipid binding site mutations in vinculin on the functional regulation of the 
protein was analysed during cell motility and adhesion. Spontaneous migration of cells 
expressing mutant and wild type GFP-vinculin was analysed in a 3D collagen matrix. The 
cells were mixed with collagen which was allowed to polymerize in a special, self 
constructed chambers. Migration of cells (n=30) in one field was followed for 15 hours 
using timelapse video microscopy. (Refer to chapter 2.2.3.7.). The tracking data collected 
manually were used to calculate the percentage of motile cells and their velocity. After an 
initial phase of adhesion to the collagen matrix the number of motile cells remained 
constant and averages (mean ± s.d.) were calculated for each of the populations between 
6-15 hours (constant phase). Vinculin LD expressing cells had a five fold reduction in 
motility (16-20%) when compared to cells expressing wild type and other vinculin 
constructs (Figure 3.12B Top row). The velocity was determined from the relative 
movement of motile cells (Figure 3.12B Bottom row). During the constant phase of 
movement (6-15 hours), the average velocity (mean ± s.d.) of vinculin-LD expressing 
cells was reduced to 53% as compared to cells expressing exogenous wild type vinculin, 
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revealing a strong inhibition of cell migration which is characterized by reduction of 
locomotory activity and also velocity. This effect was observed on a background of 
endogenous vinculin (70% of total vinculin).Values for vinculin-LD, however, were 
calculated based on rather short tracks because majority of cells registered did not 
migrate at all (Figure 3.12A). 
A 
 
 
B 
     
Figure 3.12: Migration assay in 3D collagen matrix 
A) Locomotory tracks of cells expressing GFP vinculin wild type and LD (also refer to 
supplementary movies 3.1 and 3.2) 
B) Top row: Graph represent the percentage of motile cells tracked from 0-840 hrs and 
the columns represent the average of motile cells (mean ± s.d.) during the constant phase  
(6-15 hrs). Bottom row: Graph represent the velocity of cells tracked from 0-840 hrs and 
the columns represent the average velocity of active cells (mean ± s.d.) during the 
constant phase (6-15 hrs). 
                                                                                                                        3. Results 56
3.6.4. Polarization and migration of B16-F1 populations expressing GFP vinculin 
variants on laminin 
Polarization is the initial step preceeding locomotion. The cell develops a leading edge; a 
region characterized by a high turnover of adhesion sites and increased actin 
polymerization. The cell body displays mature focal adhesions, stress fibres, and a 
trailing edge which is considered as region of adhesion dissociation and detachment.  
On laminin, B16-F1 cells display a motile phenotype that is characterized by highly 
polarized cells with wide lamellipodia at their leading front (Ballestrem et al., 1998). A 
large proportion of cells expressing GFP vinculin-wt or vinculin mutants CT and H-3 
displayed a motile phenotype after six hours of attachment on laminin. In contrast, the 
number of cells displaying this phenotype when expressing vinculin-LD was significantly 
reduced (Figure3.13A). The cells appeared bizarre with long extensions and more 
pronounced stress fibres. More than 600 cells expressing various vinculin variants were 
counted and classified into motile, non-motile and ambiguous phenotypes. The number of 
defective cells in each population was quantified. While 54% of vinculin-wt cells 
displayed a motile phenotype and only 24% did not, this ratio was inverted in the 
vinculin-LD cells with 12% polarized and motile cells, while 63% of the cells were 
spread but not polarized or showed no lamellipodia and these were judged as non-motile 
(Figure3.13C).  
Analysis of migratory capacity of individual cells on laminin using time lapse video 
microscopy detected the locomotory activity of vinculin-wt expressing cells, while not a 
single motile vinculin-LD expressing cell was detected in this assay. These differences 
are illustrated in Figure 3.14, showing selected frames taken from movies of 
representative cells expressing wt- and LD-vinculin (Refer to supplementary movies 3.3 
and 3.4).  
 
 
                                                                                                                        3. Results 57
 
Figure 3.13:  Polarization of B16-F1 populations expressing GFP-vinculin constructs 
on laminin 
Representative cells of populations expressing GFP-vinculin constructs wt (A) or LD (B), 
respectively, are stained for stress fibres with phalloidin (left) and the outlines of cells 
(right). Classification of cells in categories polarized (P), non-polarized (N) and 
ambiguous (A) was based on cell shape and the actin cytoskeleton. Bar: 10 µm.  
C) Columns represent the percentage of cells in each category taken from >600 cells 
(n=3) for each vinculin construct.  
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Figure 3.14: Time lapse video microscopy on B16-F1 cells expressing vinculin wt 
and LD  
Selected frames from movies taken in fluorescence and phase-contrast modes, illustrate 
the locomotory activity of representative cells. Bars: 10 µm.The GFP-vinculin wild type 
expressing B16-F1 melanoma cell is actively migrating as shown by a protruding 
lamellipodium, newly appearing adhesions and displacement of the nucleus. The GFP-
vinculin-LD expressing cell displays some membrane activity, but no sign of migratory 
activity (also refer to supplementary movies 3.3 and 3.4). 
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3.6.5. Adhesion and spreading of B16-F1 stable populations on various extracellular 
matrices 
Adhesion of cells to the extracellular matrix is an important physiological process that 
initiates adhesion mediated signalling, spreading and cell motility. 
The migratory capacity of the cells expressing GFP vinculin LD was observed to be 
highly reduced in the migration assays described earlier, the graph depicting cell motility 
on 3D collagen matrix had a lag phase at earlier time points (0- 120 min, Figure 3.12B)  
which could be associated with a delay in adhesion and spreading. The assays described 
below were aimed at the analysis of adhesion and spreading of cells expressing GFP 
vinculin variants on different extra cellular matrices. 
B16-F1 cells express receptors for the extracellular matrix proteins laminin (integrins 
α1β1/ α6β1), fibronectin (integrins α4β1/ α5β1) and collagen (integrin α1β1) 
(Ballestrem et al., 1996). Populations of B16-F1 cells expressing GFP-vinculin wild type 
or mutants were allowed to adhere and spread for various time periods. Comparable 
degrees of spreading were reached on laminin and fibronectin in 10 minutes after seeding 
and on collagen after 90 minutes. By that time, more than 80% of cells were spread and 
displayed peripheral lamellipodia with only a small fraction of polarized cells.  
In the adhesion assay, cells that were just attached to the surface were counted after a 
thorough washing step to remove all non-adherent cells. Cells expressing GFP vinculin 
LD showed reduced adhesion by 35% on laminin, 25% on fibronectin and 79% on 
collagen as compared to cells expressing GFP vinculin wild type (Figure 3.15). 
In the spreading assay, cells were counted in randomly selected microscopic fields (450 -
550 cells per test) and values were expressed as percentage of spread cells in each stable 
population (mean ± s.d., n=4-6). GFP vinculin-LD expressing cells displayed a decrease 
in spreading by 35 – 40% on laminin and 40 – 50% on fibronectin compared to the GFP 
vinculin-wt population. After 90 minutes of spreading on laminin or fibronectin, 
differences in the number of adherent and spread cells were decreased to less than 10% 
(Figure 3.16A and B). These results suggest that vinculin LD expression in these cells 
leads to a delay in cell adhesion and spreading. 
 
                                                                                                                        3. Results 60
 
 
Figure 3.15: Adhesion assay with various extracellular matrices 
Columns represent percentage of adherent cells on laminin, fibronectin, collagen  
(mean ± s.d) in each stable population compared to cells expressing GFP vinculin wild 
type. 
 
Figure 3.16 A 
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Figure 3.16 B 
        
 
Figure 3.16: Spreading of stable cell populations on various extracellular matrices 
A) Spreading assay showing exemplary cells in a selected microscopic field from 
populations of cells expressing vinculin wt (A), vinculin CT (B), vinculin H-3 (C)  
and vinculin LD (D) Bar: 10 µm 
B) Columns represent stable cells expressing vinculin variants that were spread, 
nonspread and those classified as ambiguous on laminin or fibronectin. 
3.6.6. Rate of incorporation of GFP vinculin variants in individual adhesion sites 
analysed by fluorescence recovery after photobleaching (FRAP) technique 
Localization of vinculin-LD in all cell types including the vinculin null cells could not be 
distinguished from vinculin wt, but stress fibres as well as number and size of adhesions 
appeared to be increased in vinculin-LD expressing stable cell populations (Figure 3.8). 
The exchange rates of vinculin molecules in individual adhesion sites in cells expressing 
vinculin LD and wt were analysed by fluorescence recovery after photobleaching 
(FRAP). The technique calculates the rate of re-incorporation of GFP-tagged vinculin 
variants after bleaching them with 100% laser intensity. Cells expressing GFP vinculin 
wt and LD were seeded on glass coverslips, mounted on special chambers for live cell 
imaging and analysed using a laser scanning microscope. Individual adhesions were 
selected, bleached by increasing the laser intensity and subjected to time lapse video 
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microscopy. Kymographs from line scans parallel to the length axis of bleached adhesion 
were generated and the half-time of fluorescence recovery was calculated based on the 
kymographs (Figure 3.17.) (Refer to chapter 2.2.3.10.). The halftime of fluorescence 
recovery after photobleaching was about 45 seconds for both wild type and lipid binding 
deficient vinculin in adhesions that remained stable for more than 10 minutes. In 
conclusion, lipid-binding deficiency of vinculin-LD does not affect incorporation and 
exchange rates of the protein in individual adhesion sites.  
 
                                                                                                         
 
 
Figure 3.17: Rate of incorporation of GFP 
vinculin variants in adhesion sites 
Cells expressing GFP tagged wt and LD 
vinculin showing individual adhesion sites 
before and after bleaching (red arrow) and the 
representative kymographs from line scans 
parallel to the length axis of bleached 
adhesions. Bar: 5 µm 
 
 
 
 
 
 
3.6.7. Retrograde sliding of adhesions as   a function of overall adhesion site turnover
in B16-F1 stable cell populations 
The exchange rates of vinculin in individual adhesion sites determined by FRAP analysis 
clearly indicated that focal adhesion targeting for both wt and LD vinculin are similar. 
The overall turnover of vinculin molecules in these adhesion sites was assumed to be 
defective, which might explain the impairment of cell migration. To analyse this 
hypothesis, live cell imaging assisted by laser scanning microscopy was performed. 
Individual adhesions were selected and followed for 20 – 30 min and the retrograde 
sliding of adhesions (translocation of adhesions towards the cell body) was registered. To 
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estimate the average speed of the sliding adhesions, more than 100 individual sites per 
vinculin variant were tracked (Figure 3.18). Adhesions containing vinculin LD in B16-F1 
cells had a five fold reduction in average speed as compared to vinculin wt expressing 
cells. The failure of adhesion translocation in vinculin LD expressing cells suggests a 
prominent stabilization of adhesion sites. The turnover of adhesion sites was also 
determined by counting the number of adhesions newly formed and dissociated in this 
period of 20 minutes in cells expressing GFP vinculin variants. From the total number of 
adhesions analysed, 27% were newly formed and 32% were disassembled in vinculin wt 
populations, whereas only 9% were formed and 2% disassembled in cells expressing 
vinculin-LD, indicating the defective turnover. Thus, the impaired cell migration could be 
attributed to the inability of vinculin LD to sense the acidic phospholipids which gives 
the signalling information to vinculin for the adhesion turnover. 
 
 
 
Figure 3.18: Retrograde 
sliding of adhesions 
Cells expressing GFP vinculin-
wt or vinculin-LD showing 
tracks of sliding adhesions 
during migration, tips of 
adhesions are marked in red.  
(t= 0-20 min). Tracks were used 
to calculate average speed of 
retrograde movement.   
Bar: 5 µm 
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3.6.8. Effect of PIP5-kinase α on B16-F1 populations expressing GFP vinculin wt 
and LD due to alterations in the PIP2 levels 
Functional impairment of GFP vinculin LD expressing B16-F1 cells suggests the 
involvement of acidic phospholipids in the focal adhesion turnover, cell migration and 
adhesion. Alterations in the PIP2 levels in these cells could possibly have different effects 
on vinculin wt and LD, since the ability of vinculin LD to sense the signals from PIP2 is 
low. PIP2 levels in these cells were altered by over-expression of murine PIP5-kinase 
α,  the kinase that catalyses the synthesis of PIP2 in cells. PIP5-kinases exist in three 
isoforms. The γ isoform localizes in focal adhesions and has been reported to bind to 
talin.  PIP5-kinase γ leads to adhesion dissociation since it competes with β-integrin for 
talin binding.Thus; the γ isoform is not ideally suited for this experiment. Hence, to 
investigate the effect of changes in PIP2 levels on GFP vinculin wt and LD turnover, 
murine PIP5-kinase α  was preferred over the other isoforms. As an internal control and 
to mark the effect of kinase activity, a “kinase dead” mutant (KD) of PIP5-kinase α was 
also expressed in these stable cell populations. 
Cells expressing GFP vinculin wt or LD and parental B16-F1 cells were plated on 
fibronectin coated coverslips, transfected with myc tagged PIP5-kinase α or bipro tagged 
PIP5-kinase α KD mutant, and were allowed to express the exogenous proteins for 12 
hours. Cells were fixed and then stained to visualize actin filaments and PIP5- kinase, 
active and kinase dead forms. Overexpression of PIP5-kinase α in GFP vinculin wt 
populations induced re-localization of vinculin from adhesion sites to the perinuclear 
region within 12 hours after transfection (Figure 3.20). This effect was quite evident also 
in parental B16-F1 cells. Within 8 hours after transfection, the endogenous vinculin was 
translocated to the perinuclear region (Figure 3.19). After 12 hours, all transfected cells 
were rounded and started to detach.  
In contrast, cells expressing GFP-vinculin-LD were quite resistant to the PIP5-kinase 
activity. Out of 60 cells co-expressing vinculin-LD and PIP5-kinase α for 12 hours 41 
cells showed vinculin-LD localized to large adhesion sites. In cells co-expressing the 
GFP vinculin variants and the PIP5-kinase α KD mutant, both GFP vinculin wt and LD 
were not re-localized indicating the need for an active kinase. These results indicate that 
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adhesions containing vinculin LD were more resistant to kinase induced elevation of 
PIP2 levels, probably due to their inefficient binding to acidic phospholipids. 
 
 
 
Figure 3.19: PIP 5-kinase α expression in parental B16-F1 cells 
A) Cells expressing PIP5-kinase α, fixed after 8 hours, showing the localization of 
endogenous vinculin (green) in few focal adhesions (lower cell), actin filaments (in grey, 
or in red in the merged image) and PIP5-kinase (blue) 
B) Control B16-F1 cells on laminin fixed after 12 hours and stained for actin filaments 
(in grey, or in red in the merged image) and endogenous vinculin (green) 
C)andC’)Cells transfected with PIP5-kinase α, fixed after 12 hours of expression 
showing re-localization of endogenous vinculin (green) to the perinuclear region, 
disorganized actin cytoskeleton (in grey, or in red in the merged image) and PIP5-kinase 
(blue) Bars: 10µm 
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Figure 3.20: PIP5-kinase α expression in stable B16-F1 populations expressing 
vinculin wt and LD 
Representative cells from stable GFP vinculin wt and LD populations co-expressing  
PIP5-kinase α wt or kinase dead (KD) forms, 12 hours after transfection. Cells were 
stained to visualize actin filaments (red), PIP5-kinase and the KD mutant (blue). GFP 
vinculin variants are shown in grey or in green (merged images). GFP vinculin wt was re-
localized to perinuclear regions by PIP5-kinase coexpression, while the vinculin LD 
expressing cells were resistant to the kinase activity (top row). Expression of KD PIP5-
kinase α does not affect the localization of either GFP vinculin wt or LD (bottom row). 
Bar: 10µm 
3.6.9. Effect of constitutively active Rac (L61) expression on GFP vinculin wt and 
LD 
Small GTPases of the Rho family (RhoA, Rac1, and Cdc42) are key regulators of 
cytoskeletal organization and have been implicated in regulation of PIP2 levels in the 
cells. RhoA and Rac1 stimulate PIP2 synthesis by activating PIP5-kinase isoforms which 
function downstream of these molecules. Recent findings indicate that synthesis of PIP2 
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via the three PIP5-kinase isoforms is controlled by RhoA, Rac1 and Cdc42 implicating 
the regulation of PIP2 levels has a central position in Rho GTPases signaling (Weernink 
et al, 2004). In order to test the effect of Rac on the regulation of PIP5-kinase isoforms, a 
constitutively active form of Rac (L61) was co-expressed in the B16-F1 vinculin wt or 
vinculin LD populations. 
B16-F1 cells expressing GFP vinculin wt or LD were seeded on fibronectin coated 
coverslips and transfected with myc tagged L61- Rac. Cells were fixed after 12 hours of 
expression and stained for actin filaments and Rac (L61). There was no evident re-
localization of GFP-vinculin wt or LD from focal adhesions in the B16-F1 stable 
populations co-expressing L61- Rac. The cells appeared to have a pancake shape 
phenotype which is typical for Rac over-expression (Figure 3.21). 
Rac is known to function upstream of the PIP5-kinase isoforms, However, 
overexpression of L61- Rac probably was not sufficient to influence the elevation of PIP2 
levels in these cells in the absence of other signals. 
 
 
Figure 3.21: L61 Rac expression in B16-F1 cells expressing GFP vinculin wt and LD 
Cells expressing GFP vinculin wt and LD (green) transfected with Rac (L61), fixed after 
12 hours of expression and stained to visualize Rac (blue), actin filaments (red) 
representing both vinculin wt and LD in adhesion sites. (Grey and merged pictures) 
Bar: 10 µm 
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4. Discussion 
 
Many cytoskeletal proteins bind to and in some cases are functionally regulated by 
specific membrane lipids. The molecular basis for such interactions is now beginning to 
be understood. More insights into the physiological role of these interactions can be 
obtained with a better knowledge about the molecular structure of specific lipid binding 
sites (Niggli, 2001). This will aid in the construction of mutant proteins lacking the 
ability to interact with lipids. Careful analyses of the biochemical properties and cellular 
expression of these mutant proteins can provide information on the functional regulation 
of these proteins through lipids. This work focused on the acid phospholipid-mediated 
regulation of the cell adhesion protein vinculin. Design and construction of a lipid 
binding site mutant allowed us to characterize the role of lipids in activation and 
regulation of this protein with more relevance to its functional role in cell adhesion and 
migration. The following section will discuss the major facts on regulation of vinculin in 
adhesion sites that were derived from several biochemical and cell biological analyses of 
the lipid binding deficient mutant “Vinculin-LD”. 
4.1. “Vinculin-LD” shows decreased binding to acidic phospholipids 
Binding of vinculin to acidic phospholipids, more specifically to PIP2, was reported long 
back (Fukami et al. 1994) and was believed to regulate the actin cytoskeleton. 
Significance of PIP2 interaction with vinculin has already been discussed in the earlier 
chapters (Refer to chapter 1.3.4). Construction of a lipid binding deficient mutant to 
further analyse the functional regulation of vinculin by PIP2 was therefore considered 
essential. The molecular structure of vinculin describes the cluster of basic residues 
(lysines and arginines) in the basic ladder (helix 2 and helix 3) and the basic collar as 
lipid binding sites (Bakolitsa et al. 1999). Several attempts were made by various 
research groups to generate a lipid binding deficient mutant and thereafter to analyse its 
functional consequence on cell adhesion, spreading and migration. In a preliminary 
report, alanine substitution of the c-terminal basic residues of vinculin abolished binding 
to 10%PIP2/90%PC vesicles in vitro while leaving the focal adhesion targeting 
unimpaired (Cohen and Craig, 2003). Another C-terminal mutant lacking the terminal 15 
amino acids, Vt∆C, failed to cosediment with multilamellar vesicles composed of PS, PC 
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and PIP2 at physiological pH. On lowering the pH, cosedimentation was observed with a 
midpoint at pH 6.5. Very little cosedimentation occurred with PC vesicles, showing that 
the mutant retained its specificity for acidic phospholipids (Bakolitsa et al.1999). 
Expression of this mutant in vinculin null MEF cells was unable to restore normal rates 
of cell spreading and showed mislocalization of the protein to the fibrillar adhesions 
instead of the peripheral adhesions (Saunders et al. 2003). The vinculin tail mutants with 
alanine substitutions (eg: Vt W1058A, Vt K911A, Vt DM (R910/K911A), Vt TM 
(R910/K911/K915A), Vt K924A) showed upto 50% reduced binding to the vesicles 
containing 40%PIP2/60%PC (Bakolitsa et al. 2004). In the work presented here, a 
combination of point mutations in the basic ladder and basic collar in Vt-LD has 
completely abolished the acidic phospholipids binding (chapter 3.5.1). It includes the 
point mutation of amino acids K952, R1060, K1061 which were already described in few 
of the above stated examples to have an effect on the lipid binding capacity. Other 
mutants including Vt ∆1052, Vt H-3, Vt CT have about 50% reduction in their acidic 
phospholipid binding indicating the significance of both the binding sites in the lipid 
interaction. 
4.2. Interaction to specific ligands is intact in “Vinculin-LD” 
Vinculin is a modular protein having binding sites for numerous cytoskeletal and actin 
reorganizing proteins (Jockusch and Rüdiger, 1996, Critchley DR, 2000). The lipid 
binding sites in the C-terminus (basic collar) and the helix 3 (basic ladder) has flanking 
sequence regions that interact with vinculin tail and actin. Vinculin head-tail interaction 
is essential to maintain its inactive conformation as described earlier. F-actin is an 
important ligand which mediates the membrane-cytoskeleton connection. The point 
mutations at the lipid binding sites were carefully designed to avoid any influence on its 
ligand interactions. The intramolecular head-tail interaction, tested in a GST pull down 
assay was found to be intact (Chapter 3.5.3.). Interaction of actin with vinculin has 
always been controversial and was considered to be mutually exclusive with PIP2 
interactions (Steimle et al. 1999). The binding capacity between F-actin and vinculin was 
estimated to be 0.3 – 0.6 moles of vinculin tail per mole of actin (Johnson and Craig, 
1995). When a molar ratio of actin:Vt of 2:1 was employed in the actin cosedimentation 
assay, the concentration of F-actin was exceeding the maximum binding capacity stated 
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above which could be a possible reason for the 35% decrease in Vt binding (Chapter 
3.5.2.). However, the binding affinities for the Vt wt and Vt CT mutant were found to be 
normal at this molar ratio. Hence, one can conclude that the mutations in the helix 3 lipid 
binding site may have a slight influence on the “vinculin-LD” interaction with actin at 
higher molar ratios, but it does not block the interaction.  
4.3. The interaction with acidic phospholipids is not crucial for the localization of 
vinculin 
Interaction of PIP2 with vinculin was supposed to release the intramolecular head-tail 
binding, converting the molecule to the active conformation and permitting various 
ligand interactions and focal adhesion targeting (Gilmore and Burridge, 1996, Weekes et 
al. 1996). Hence, one might conclude that a vinculin deficient in lipid binding should not 
localize to the focal adhesions. However “vinculin-LD” expressed in B16-F1 cells 
perfectly localized to the FA’s and co-localized with paxillin, a focal adhesion marker 
(Chapter 3.6.2). Endogenous vinculin present in the melanoma cells might guide the FA 
targeting through formation of tail hetero-oligomers (Hüttelmaier et al. 1997). However, 
when expressed in vinculin (–/–) MEF cells (Xu et al., 1998a), vinculin-LD still localized 
to focal adhesions (Chapter 3.6.2.). Hence, recruitment of vinculin-LD to adhesion sites 
is apparently independent of phospholipid binding and subsequent activation of the 
molecule. This confirms that PIP2 interaction with vinculin is not essential for vinculin 
activation and focal adhesion targeting as previously stated, instead, lipid binding should 
be considered important in the regulation of adhesion site turnover which will be 
discussed below 
4.4. “Vinculin-LD” acts as a dominant negative mutant and affects cell adhesion and 
migration 
Cell adhesion and migration are two basic cellular processes that require a regulated 
interplay of actin dynamics and turnover of cell-matrix adhesions (Pollard and Borisy, 
2003, Gumbinier et al. 1996). Vinculin is a major structural and regulatory component of 
these adhesions sites, involved in the force coupling and stabilization of nascent FA’s 
after talin binding to integrin (Galbraith et al. 2002, Giannone et al. 2003). Cell migration 
was shown to be inhibited in vinculin overexpressing cells and a decrease in vinculin 
levels promoted cell motility (Rodriguez Fernandez et al. 1992, Rodriguez Fernandez et 
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al. 1993). Vinculin deficient mouse embryonic fibroblasts have a defect in cell spreading, 
but they migrate much faster than control cells (Xu et al. 1998a, Xu et al. 1998b) due to 
the failure to stabilize initial adhesions. “Vinculin-LD” expressing mouse melanoma cells 
display a delay in cell adhesion on various extra cellular matrix components (Chapter 
3.6.5). Migration of these cells was also grossly impaired on 3D collagen matrix (Chapter 
3.6.3) and on laminin (Chapter 3.6.4).  
Cell spreading requires an increased turnover of small, transient adhesion sites in the 
peripheral lamellipodia which are controlled by the Rac or Rho GTPases (Rottner et al. 
1999). Activities of non receptor tyrosine kinases like FAK and Src-kinase play an 
important role in cell spreading (Von Wichert et al. 2003). Increased FAK activity has a 
negative influence on the residence life time of vinculin and paxillin in adhesion sites 
(Von Wichert et al. 2003), leading to enhanced adhesion site turnover. Defective 
spreading of vinculin null fibroblasts was attributed to high FAK activity in these cells 
(Xu et al. 1998a). B16-F1 cells expressing “Vinculin-LD” also have a delay in cell 
spreading on laminin and fibronectin (Chapter 3.6.5) which could be attributed to the 
decreased adhesion site turnover (Chapter 4.5). These results clearly prove that vinculin 
deficient in lipid binding is unable to functionally regulate actin dynamics and adhesion 
site turnover and is thus acting as a “dominant negative”, seriously affecting cell 
adhesion, migration and spreading on various extracellular matrices. 
4.5. Incorporation of “Vinculin-LD” in adhesion sites is normal 
Basal exchange rates of vinculin in individual adhesion sites was similar for both GFP 
vinculin wt and –LD mutant as judged by the FRAP analysis (Chapter 3.6.6.). This gives 
an additional proof for the PIP2 independent activation and focal adhesion targeting of 
vinculin, including the localization studies on various cell types. Thus, the recruitment of 
vinculin to focal adhesions is independent of acidic phopholipid binding, which is 
consistent with preliminary reports from other groups, who observed that different lipid 
binding site mutations in the vinculin tail did not affect its subcellular localization. For 
example, the alanine substitution mutants had decreased binding affinity to lipid vesicles 
but their localization to FA’s was not altered (Cohen and Craig, 2003). Various vinculin 
mutants carrying point mutations in the basic collar or the basic ladder were found to 
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localize perfectly in FA’s (Saunders et al. 2003). Vt∆C, lacking the c-terminal 15 amino 
acids is the only reported mutant to have slightly altered localization to the fibrillar 
adhesions rather than to the peripheral adhesions (Saunders et al. 2003). However, the 
analysis of the retrograde sliding of individual adhesions reveals a defect in the over all 
turnover of the adhesion sites, providing a simple explanation for the observed decrease 
in cell migration. 
4.6. A proposed mechanism for vinculin activation and regulation at the focal 
adhesions – lessons learnt from “Vinculin-LD” 
Interaction of vinculin with actin and the acidic phospholipid PIP2 is mutually exclusive 
and PIP2 interaction unmasks the talin binding site in the vinculin head while blocking 
the actin binding site in the vinculin tail (Stiemle et al. 1999). In other words, vinculin 
bound to PIP2 is membrane associated and is not bound directly to actin. Thus, these two 
ligands provide alternative pathways for vinculin activation and regulation at the 
adhesion sites (Bakolitsa et al. 2004).  
In wild type cells, PIP2 acts as an important signaling molecule that regulates adhesion 
site turnover. Low levels of PIP2 seem to trigger cell adhesion and stabilize nascent focal 
adhesions. In vinculin-LD expressing cells, the PIP2 level is not monitored correctly, 
even when endogenous vinculin is still present. An increase in the PIP2 level, as may be 
the result of external signaling, is immediately recognized by vinculin at these sites in the 
wild type cells. Consequently, vinculin is dissociating from the actin cytoskeleton which 
results in enhanced adhesion site turnover. In contrast, “vinculin-LD”, localized correctly 
to intact adhesions, is unable to respond to the release signals and focal adhesion turnover 
is impaired. This results in a defective interaction between integrins and the actin 
cytoskeleton, and affects cell spreading. By the same mechanism, the afflicted cells are 
unable to become polarized and to develop lamellipodia, which leads to their unability to 
migrate. These events are schematically depicted in Figure 4.1. 
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Figure 4.1: Model of vinculin involvement in adhesion site turnover 
In motile cells, areas with both high adhesion turnover and high actin dynamics depend 
on elevated PIP2-levels, which leads to a weakening of the vinculin-actin interaction and 
subsequent turnover of adhesion sites. In case of vinculin-LD expressing cells adhesion 
sites are stabilized and efficient progression of lamellipodia is impaired. This leads to a 
delay in cell spreading and an almost complete inhibition of cell motility.  
4.7. Vinculin acts as a sensor in lipid mediated regulation of the adhesion sites 
The points discussed above strongly suggest a lipid-dependent regulation of vinculin in 
the adhesion sites. Increase in cellular PIP2 levels could trigger the release of vinculin 
from adhesions and this was tested by over expression of murine PIP5-kinase α (Tolias et 
al. 2000). Expression of PIP5-kinase lead to membrane localization of this kinase and to 
increased PIP2 synthesis (Doughman et al. 2003). However, vinculin-LD expressing cells 
were more resistant to the release signals mediated through increased PIP2 levels when 
compared to the vinculin wt (Chapter 3.6.8). Vinculin wt very efficiently sensed the 
elevated PIP2 levels which resulted in adhesion dissociation and cell detachment. In 
contrast, “vinculin-LD” was unable to sense the change in PIP2 levels due to the 
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deficiency in lipid binding capacity. Thus, vinculin acts as a sensor that converts the local 
modulation of PIP2 levels into adhesion site dynamics. 
 
4.8. Future prospects 
“Vinculin-LD” could serve as a tool to further analyse the adhesion site dynamics. 
Molecular players that are involved in the assembly and disassembly of focal adhesions 
can be evaluated in terms of their interaction with vinculin and PIP2. This could pave the 
way to an improved understanding of cell adhesion and migration.  
In the presence of “vinculin-LD”, the analysis of the incorporation rates of various FA 
markers like talin, paxillin should give more information on the assembly of focal 
adhesions and on the changes that occur in the early and later stages of maturation, and 
during disassembly. The influence of PIP2 on the association of vinculin binding partners 
like protein kinase C and the Arp2/3 complex could also be analysed with “vinculin-
LD”expressing cells. For all such studies, the fact that vinculin-LD acts as a dominant 
negative is advantageous, as the effects of this mutant, as reported here, is seen on top of 
the endogenous vinculin level.  
On the other hand, “vinculin-LD” expression in vinculin null cells and further analyses of 
the molecular components of the focal adhesions in such cells could aid more insight into 
the architecture and regulation of such altered adhesion sites. 
 
 
 
 
 
 
 
                                                                                                                5. References 75
5. References 
 
Abercrombie, M., Heaysman, J. E. and Pegrum, S. M. (1971). The locomotion of 
fibroblasts in culture. IV. Electron microscopy of the leading lamella. Exp Cell Res 67, 
359-67. 
 
Arneson, L. S., Kunz, J., Anderson, R. A. and Traub, L. M. (1999). Coupled inositide 
phosphorylation and phospholipase D activation initiates clathrin-coat assembly on 
lysosomes. J Biol Chem 274, 17794-805. 
 
Auger, K. R., Serunian, L. A., Soltoff, S. P., Libby, P. and Cantley, L. C. (1989). 
PDGF-dependent tyrosine phosphorylation stimulates production of novel 
polyphosphoinositides in intact cells. Cell 57, 167-75. 
 
Bakolitsa, C., Cohen, D. M., Bankston, L. A., Bobkov, A. A., Cadwell, G. W., 
Jennings, L., Critchley, D. R., Craig, S. W. and Liddington, R. C. (2004). Structural 
basis for vinculin activation at sites of cell adhesion. Nature 430, 583-6. 
 
Bakolitsa, C., de Pereda, J. M., Bagshaw, C. R., Critchley, D. R. and Liddington, R. 
C. (1999). Crystal structure of the vinculin tail suggests a pathway for activation. Cell 99, 
603-13. 
 
Balla, T., Bondeva, T. and Varnai, P. (2000). How accurately can we image inositol 
lipids in living cells? Trends Pharmacol Sci 21, 238-41. 
 
Ballestrem, C., Wehrle-Haller, B. and Imhof, B. (1998). Actin dynamics in living 
mammalian cells. J Cell Sci 111, 1649-1658. 
 
Ballestrem, C. G., Uniyal, S., McCormick, J. I., Chau, T., Singh, B. and Chan, B. M. 
(1996). VLA-beta 1 integrin subunit-specific monoclonal antibodies MB1.1 and MB1.2: 
binding to epitopes not dependent on thymocyte development or regulated by phorbol 
ester and divalent cations. Hybridoma 15, 125-32. 
 
Barret, C., Roy, C., Montcourrier, P., Mangeat, P. and Niggli, V. (2000). Mutagenesis 
of the phosphatidylinositol 4,5-bisphosphate (PIP(2)) binding site in the NH(2)-terminal 
domain of ezrin correlates with its altered cellular distribution. J Cell Biol 151, 1067-80. 
 
Barstead, R. J. and Waterston, R. H. (1991). Vinculin is essential for muscle function 
in the nematode. J Cell Biol 114, 715-24. 
 
Bass, M. D., Smith, B. J., Prigent, S. A. and Critchley, D. R. (1999). Talin contains 
three similar vinculin-binding sites predicted to form an amphipathic helix. Biochem J 
341 ( Pt 2), 257-63. 
 
                                                                                                                5. References 76
Berridge, M. J. and Irvine, R. F. (1984). Inositol trisphosphate, a novel second 
messenger in cellular signal transduction. Nature 312, 315-21. 
 
Bielas, S. L. and Gleeson, J. G. (2004). Cytoskeletal-associated proteins in the 
migration of cortical neurons. J Neurobiol 58, 149-59. 
 
Brindle, N. P., Holt, M. R., Davies, J. E., Price, C. J. and Critchley, D. R. (1996). The 
focal-adhesion vasodilator-stimulated phosphoprotein (VASP) binds to the proline-rich 
domain in vinculin. Biochem J 318 ( Pt 3), 753-7. 
 
Burridge, K. and Mangeat, P. (1984). An interaction between vinculin and talin. Nature 
308, 744-6. 
 
Burridge, K., Turner, C. E. and Romer, L. H. (1992). Tyrosine phosphorylation of 
paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in 
cytoskeletal assembly. J Cell Biol 119, 893-903. 
 
Campbell, K. P. (1995). Adhalin gene mutations and autosomal recessive limb-girdle 
muscular dystrophy. Ann Neurol 38, 353-4. 
 
Carragher, N. O. and Frame, M. C. (2004). Focal adhesion and actin dynamics: a place 
where kinases and proteases meet to promote invasion. Trends Cell Biol 14, 241-9. 
 
Carragher, N. O., Levkau, B., Ross, R. and Raines, E. W. (1999). Degraded collagen 
fragments promote rapid disassembly of smooth muscle focal adhesions that correlates 
with cleavage of pp125(FAK), paxillin, and talin. J Cell Biol 147, 619-30. 
 
Chen, H., Ishii, A., Wong, W. K., Chen, L. B. and Lo, S. H. (2000). Molecular 
characterization of human tensin. Biochem J 351 Pt 2, 403-11. 
 
Cohen, D. M. and Craig, S. W. (2003). A cell-free system to investigate the role of 
inositol phospholipids in vinculin recruitment to focal adhesions. Mol. Biol. Cell 14, 63a. 
 
Coutu, M. D. and Craig, S. W. (1988). cDNA-derived sequence of chicken embryo 
vinculin. Proc Natl Acad Sci U S A 85, 8535-9. 
 
Critchley, D. R. (2000). Focal adhesions - the cytoskeletal connection. Curr Opin Cell 
Biol 12, 133-9. 
 
Crowley, E. and Horwitz, A. F. (1995). Tyrosine phosphorylation and cytoskeletal 
tension regulate the release of fibroblast adhesions. J Cell Biol 131, 525-37. 
 
Cunningham, C. C., Gorlin, J. B., Kwiatkowski, D. J., Hartwig, J. H., Janmey, P. A., 
Byers, H. R. and Stossel, T. P. (1992). Actin-binding protein requirement for cortical 
stability and efficient locomotion. Science 255, 325-7. 
 
                                                                                                                5. References 77
DeMali, K. A., Barlow, C. A. and Burridge, K. (2002). Recruitment of the Arp2/3 
complex to vinculin: coupling membrane protrusion to matrix adhesion. J Cell Biol 159, 
881-91. 
 
DiPaolo, G., Pellegrini, L., Letinic, K., Cestra, G., Zoncu, R., Voronov, S., Chang, S., 
Guo, J., Wenk, M. R. and De Camilli, P. (2002). Recruitment and regulation of 
phosphatidylinositol phosphate kinase type 1gamma by the FERM domain of talin. 
Nature 420, 85-9. 
 
Doughman, R. L., Firestone, A. J. and Anderson, R. A. (2003). Phosphatidylinositol 
phosphate kinases put PI4,5P(2) in its place. J Membr Biol 194, 77-89. 
 
Friedl, P., Hegerfeldt, Y. and Tusch, M. (2004). Collective cell migration in 
morphogenesis and cancer. Int J Dev Biol 48, 441-9. 
 
Fukami, K., Endo, T., Imamura, M. and Takenawa, T. (1994). alpha-Actinin and 
vinculin are PIP2-binding proteins involved in signaling by tyrosine kinase. J. Biol. 
Chem. 269, 1518-1522. 
 
Furuhashi, K., Inagaki, M., Hatano, S., Fukami, K. and Takenawa, T. (1992). 
Inositol phospholipid-induced suppression of F-actin-gelating activity of smooth muscle 
filamin. Biochem Biophys Res Commun 184, 1261-5. 
 
Galbraith, C. G., Yamada, K. M. and Sheetz, M. P. (2002). The relationship between 
force and focal complex development. J Cell Biol 159, 695-705. 
 
Garrod, D. R. (1993). Desmosomes and hemidesmosomes. Curr Opin Cell Biol 5, 30-
40. 
 
Geiger, B. (1979). A 130K protein from chicken gizzard: its localization at the termini of 
microfilament bundles in cultured chicken cells. Cell 18, 193-205. 
 
Geiger, B. and Ginsberg, D. (1991). The cytoplasmic domain of adherens-type 
junctions. Cell Motil Cytoskeleton 20, 1-6. 
 
Geiger, B., Tokuyasu, K. T., Dutton, A. H. and Singer, S. J. (1980). Vinculin, an 
intracellular protein localized at specialized sites where microfilament bundles terminate 
at cell membranes. Proc Natl Acad Sci U S A 77, 4127-31. 
 
Giannone, G., Jiang, G., Sutton, D. H., Critchley, D. R. and Sheetz, M. P. (2003). 
Talin1 is critical for force-dependent reinforcement of initial integrin-cytoskeleton bonds 
but not tyrosine kinase activation. J. Cell Biol. 163, 409-419. 
 
Gilmore, A. P. and Burridge, K. (1996). Regulation of vinculin binding to talin and 
actin by phosphatidyl-inositol-4-5-bisphosphate. Nature 381, 531-5. 
 
                                                                                                                5. References 78
Gumbiner, B. M. (1996). Cell adhesion: the molecular basis of tissue architecture and 
morphogenesis. Cell 84, 345-57. 
 
Heiska, L., Alfthan, K., Gronholm, M., Vilja, P., Vaheri, A. and Carpen, O. (1998). 
Association of ezrin with intercellular adhesion molecule-1 and -2 (ICAM-1 and ICAM-
2). Regulation by phosphatidylinositol 4, 5-bisphosphate. J Biol Chem 273, 21893-900. 
 
Heiss, S. G. and Cooper, J. A. (1991). Regulation of CapZ, an actin capping protein of 
chicken muscle, by anionic phospholipids. Biochemistry 30, 8753-8. 
 
Hirao, M., Sato, N., Kondo, T., Yonemura, S., Monden, M., Sasaki, T., Takai, Y. 
and Tsukita, S. (1996). Regulation mechanism of ERM (ezrin/radixin/moesin) 
protein/plasma membrane association: possible involvement of phosphatidylinositol 
turnover and Rho-dependent signaling pathway. J Cell Biol 135, 37-51. 
 
Hüttelmaier, S., Bubeck, P., Rudiger, M. and Jockusch, B. M. (1997). 
Characterization of two F-actin-binding and oligomerization sites in the cell-contact 
protein vinculin. Eur J Biochem 247, 1136-42. 
 
Hüttelmaier, S., Mayboroda, O., Harbeck, B., Jarchau, T., Jockusch, B. M. and 
Rudiger, M. (1998). The interaction of the cell-contact proteins VASP and vinculin is 
regulated by phosphatidylinositol-4,5-bisphosphate. Curr Biol 8, 479-88. 
 
Huttenlocher, A., Sandborg, R. R. and Horwitz, A. F. (1995). Adhesion in cell 
migration. Curr Opin Cell Biol 7, 697-706. 
Huttenlocher, P. R., Taravath, S. and Mojtahedi, S. (1994). Periventricular 
heterotopia and epilepsy. Neurology 44, 51-5. 
 
Ishihara, H., Shibasaki, Y., Kizuki, N., Katagiri, H., Yazaki, Y., Asano, T. and Oka, 
Y. (1996). Cloning of cDNAs encoding two isoforms of 68-kDa type I 
phosphatidylinositol-4-phosphate 5-kinase. J Biol Chem 271, 23611-4. 
 
Ishihara, H., Shibasaki, Y., Kizuki, N., Wada, T., Yazaki, Y., Asano, T. and Oka, Y. 
(1998). Type I phosphatidylinositol-4-phosphate 5-kinases. Cloning of the third isoform 
and deletion/substitution analysis of members of this novel lipid kinase family. J Biol 
Chem 273, 8741-8. 
 
Itoh, T., Ishihara, H., Shibasaki, Y., Oka, Y. and Takenawa, T. (2000). 
Autophosphorylation of type I phosphatidylinositol phosphate kinase regulates its lipid 
kinase activity. J Biol Chem 275, 19389-94. 
 
Izard, T., Evans, G., Borgon, R. A., Rush, C. L., Bricogne, G. and Bois, P. R. (2004). 
Vinculin activation by talin through helical bundle conversion. Nature 427, 171-5. 
 
Izzard, C. S. and Lochner, L. R. (1980). Formation of cell-to-substrate contacts during 
fibroblast motility: an interference-reflexion study. J Cell Sci 42, 81-116. 
                                                                                                                5. References 79
 
Janmey, P. A. and Stossel, T. P. (1987). Modulation of gelsolin function by 
phosphatidylinositol 4,5-bisphosphate. Nature 325, 362-4. 
 
Jay, P. Y., Pham, P. A., Wong, S. A. and Elson, E. L. (1995). A mechanical function of 
myosin II in cell motility. J Cell Sci 108 ( Pt 1), 387-93. 
 
Jockusch, B. M. and Isenberg, G. (1981). Interaction of alpha-actinin and vinculin with 
actin: opposite effects on filament network formation. Proc Natl Acad Sci U S A 78, 
3005-9. 
 
Jockusch, B. M. and Rudiger, M. (1996). Crosstalk between cell adhesion molecules: 
vinculin as a paradigm for regulation by conformation. Trends Cell Biol 6, 311-315. 
 
Johnson, R. P. and Craig, S. W. (1994). An intramolecular association between the 
head and tail domains of vinculin modulates talin binding. J Biol Chem 269, 12611-9. 
 
Johnson, R. P. and Craig, S. W. (1995). F-actin binding site masked by the 
intramolecular association of vinculin head and tail domains. Nature 373, 261-4. 
 
Johnson, R. P., Niggli, V., Durrer, P. and Craig, S. W. (1998). A conserved motif in 
the tail domain of vinculin mediates association with and insertion into acidic 
phospholipid bilayers. Biochemistry 37, 10211-22. 
 
Johnson, Z., Power, C. A., Weiss, C., Rintelen, F., Ji, H., Ruckle, T., Camps, M., 
Wells, T. N., Schwarz, M. K., Proudfoot, A. E. et al. (2004). Chemokine inhibition--
why, when, where, which and how? Biochem Soc Trans 32, 366-77. 
 
Kioka, N., Sakata, S., Kawauchi, T., Amachi, T., Akiyama, S. K., Okazaki, K., Yaen, 
C., Yamada, K. M. and Aota, S. (1999). Vinexin: a novel vinculin-binding protein with 
multiple SH3 domains enhances actin cytoskeletal organization. J Cell Biol 144, 59-69. 
Kroemker, M., Rudiger, A. H., Jockusch, B. M. and Rudiger, M. (1994). 
Intramolecular interactions in vinculin control alpha-actinin binding to the vinculin head. 
FEBS Lett 355, 259-62. 
 
Kumar, N. M. and Gilula, N. B. (1996). The gap junction communication channel. Cell 
84, 381-8. 
 
Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head 
of bacteriophage T4. Nature 227, 680-5. 
 
Lauffenburger, D. A. and Horwitz, A. F. (1996). Cell migration: a physically 
integrated molecular process. Cell 84, 359-69. 
 
                                                                                                                5. References 80
Ling, K., Doughman, R. L., Firestone, A. J., Bunce, M. W. and Anderson, R. A. 
(2002). Type I gamma phosphatidylinositol phosphate kinase targets and regulates focal 
adhesions. Nature 420, 89-93. 
 
Locascio, A. and Nieto, M. A. (2001). Cell movements during vertebrate development: 
integrated tissue behaviour versus individual cell migration. Curr Opin Genet Dev 11, 
464-9. 
 
Machesky, L. M., Atkinson, S. J., Ampe, C., Vandekerckhove, J. and Pollard, T. D. 
(1994). Purification of a cortical complex containing two unconventional actins from 
Acanthamoeba by affinity chromatography on profilin-agarose. J Cell Biol 127, 107-15. 
 
Machesky, L. M. and Insall, R. H. (1998). Scar1 and the related Wiskott-Aldrich 
syndrome protein, WASP, regulate the actin cytoskeleton through the Arp2/3 complex. 
Curr Biol 8, 1347-56. 
 
Mandai, K., Nakanishi, H., Satoh, A., Takahashi, K., Satoh, K., Nishioka, H., 
Mizoguchi, A. and Takai, Y. (1999). Ponsin/SH3P12: an l-afadin- and vinculin-binding 
protein localized at cell-cell and cell-matrix adherens junctions. J Cell Biol 144, 1001-17. 
 
Martel, V., Racaud-Sultan, C., Dupe, S., Marie, C., Paulhe, F., Galmiche, A., Block, 
M. R. and Albiges-Rizo, C. (2001). Conformation, localization and integrin-binding of 
talin depend on its interaction with phosphoinositides. J Biol Chem 276, 21217-27. 
 
Martin, P. and Parkhurst, S. M. (2004). Parallels between tissue repair and embryo 
morphogenesis. Development 131, 3021-34. 
 
McLaughlin, S., Wang, J., Gambhir, A. and Murray, D. (2002). PIP(2) and proteins: 
interactions, organization, and information flow. Annu Rev Biophys Biomol Struct 31, 
151-75. 
 
Meerschaert, K., De Corte, V., De Ville, Y., Vandekerckhove, J. and Gettemans, J. 
(1998). Gelsolin and functionally similar actin-binding proteins are regulated by 
lysophosphatidic acid. Embo J 17, 5923-32. 
 
Menkel, A. R., Kroemker, M., Bubeck, P., Ronsiek, M., Nikolai, G. and Jockusch, B. 
M. (1994). Characterization of an F-actin-binding domain in the cytoskeletal protein 
vinculin. J Cell Biol 126, 1231-40. 
 
Miller, G. J., Dunn, S. D. and Ball, E. H. (2001). Interaction of the n- and c-terminal 
domains of vinculin. characterization and mapping studies. J Biol Chem 276, 11729-34. 
 
Miyazawa, A., Umeda, M., Horikoshi, T., Yanagisawa, K., Yoshioka, T. and Inoue, 
K. (1988). Production and characterization of monoclonal antibodies that bind to 
phosphatidylinositol 4,5-bisphosphate. Mol Immunol 25, 1025-31. 
 
                                                                                                                5. References 81
Mogilner, A. and Oster, G. (1996). Cell motility driven by actin polymerization. 
Biophys J 71, 3030-45. 
 
Molony, L. and Burridge, K. (1985). Molecular shape and self-association of vinculin 
and metavinculin. J Cell Biochem 29, 31-6. 
 
Nakamura, F., Huang, L., Pestonjamasp, K., Luna, E. J. and Furthmayr, H. (1999). 
Regulation of F-actin binding to platelet moesin in vitro by both phosphorylation of 
threonine 558 and polyphosphatidylinositides. Mol Biol Cell 10, 2669-85. 
 
Nakashima, S. (2002). Protein kinase C alpha (PKC alpha): regulation and biological 
function. J Biochem (Tokyo) 132, 669-75. 
 
Niggemann, B., Maaser, K., Lu, H., Kroczek, R., Zanker, K. S. and Friedl, P. (1997). 
Locomotory phenotypes of human tumor cell lines and T lymphocytes in a three-
dimensional collagen lattice. Cancer Lett 118, 173-80. 
 
Niggli, V. (2001). Structural properties of lipid-binding sites in cytoskeletal proteins. 
Trends Biochem Sci 26, 604-11. 
 
Niggli, V. and Gimona, M. (1993). Evidence for a ternary interaction between alpha-
actinin, (meta)vinculin and acidic-phospholipid bilayers. Eur J Biochem 213, 1009-15. 
 
Nobes, C. D. and Hall, A. (1995). Rho, rac, and cdc42 GTPases regulate the assembly of 
multimolecular focal complexes associated with actin stress fibers, lamellipodia, and 
filopodia. Cell 81, 53-62. 
 
Ojala, P. J., Paavilainen, V. and Lappalainen, P. (2001). Identification of yeast cofilin 
residues specific for actin monomer and PIP2 binding. Biochemistry 40, 15562-9. 
 
Papagrigoriou, E., Gingras, A. R., Barsukov, I. L., Bate, N., Fillingham, I. J., Patel, 
B., Frank, R., Ziegler, W. H., Roberts, G. C., Critchley, D. R. et al. (2004). Activation 
of a vinculin-binding site in the talin rod involves rearrangement of a five-helix bundle. 
Embo J 23, 2942-2951. 
 
Pokutta, S. and Weis, W. I. (2002). The cytoplasmic face of cell contact sites. Curr 
Opin Struct Biol 12, 255-62. 
 
Pollard, T. D. and Borisy, G. G. (2003). Cellular motility driven by assembly and 
disassembly of actin filaments. Cell 112, 453-65. 
 
Price, G. J., Jones, P., Davison, M. D., Patel, B., Bendori, R., Geiger, B. and 
Critchley, D. R. (1989). Primary sequence and domain structure of chicken vinculin. 
Biochem J 259, 453-61. 
                                                                                                                5. References 82
Reinhard, M., Rudiger, M., Jockusch, B. M. and Walter, U. (1996). VASP interaction 
with vinculin: a recurring theme of interactions with proline-rich motifs. FEBS Lett 399, 
103-7. 
 
Ridley, A. (2000). Molecular switches in metastasis. Nature 406, 466-7. 
 
Ridley, A. J. and Hall, A. (1992). The small GTP-binding protein rho regulates the 
assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70, 
389-99. 
 
Ridley, A. J., Schwartz, M. A., Burridge, K., Firtel, R. A., Ginsberg, M. H., Borisy, 
G.,  
Parsons, J. T. and Horwitz, A. R. (2003). Cell Migration: Integrating Signals from 
Front to Back. Science 302, 1704-1709. 
 
Riento, K. and Ridley, A. J. (2003). Rocks: multifunctional kinases in cell behaviour. 
Nat Rev Mol Cell Biol 4, 446-56. 
 
Rodriguez Fernandez, J. L., Geiger, B., Salomon, D. and Ben-Ze'ev, A. (1992). 
Overexpression of vinculin suppresses cell motility in BALB/c 3T3 cells. Cell Motil 
Cytoskeleton 22, 127-34. 
 
Rodriguez Fernandez, J. L., Geiger, B., Salomon, D. and Ben-Ze'ev, A. (1993). 
Suppression of vinculin expression by antisense transfection confers changes in cell 
morphology, motility, and anchorage-dependent growth of 3T3 cells. J Cell Biol 122, 
1285-94. 
 
Rohatgi, R., Ho, H. Y. and Kirschner, M. W. (2000). Mechanism of N-WASP 
activation by CDC42 and phosphatidylinositol 4, 5-bisphosphate. J Cell Biol 150, 1299-
310. 
 
Rottner, K., Hall, A. and Small, J. V. (1999). Interplay between Rac and Rho in the 
control of substrate contact dynamics. Curr Biol 9, 640-8. 
 
Rozelle, A. L., Machesky, L. M., Yamamoto, M., Driessens, M. H., Insall, R. H., 
Roth, M. G., Luby-Phelps, K., Marriott, G., Hall, A. and Yin, H. L. (2000). 
Phosphatidylinositol 4,5-bisphosphate induces actin-based movement of raft-enriched 
vesicles through WASP-Arp2/3. Curr Biol 10, 311-20. 
 
Rudiger, M., Jockusch, B. M. and Rothkegel, M. (1997). Epitope tag-antibody 
combination useful for the detection of protein expression in prokaryotic and eukaryotic 
cells. Biotechniques 23, 96-7. 
 
Sanchez-Madrid, F. and del Pozo, M. A. (1999). Leukocyte polarization in cell 
migration and immune interactions. Embo J 18, 501-11. 
 
                                                                                                                5. References 83
Saunders, R., Jennings, L., Sutton, D. H., Barsukov, I., Holt, M. R., Dunn, G. A., 
Adamson, E. D. and Critchley, D. R. (2003). Vinculin mutations that decrease PIP2 
binding lead to protein mislocalisation and failure to rescue cell spreading defects in 
vinculin null fibroblasts. Mol. Biol. Cell 14, 63a. 
 
Schafer, D. A., Jennings, P. B. and Cooper, J. A. (1996). Dynamics of capping protein 
and actin assembly in vitro: uncapping barbed ends by polyphosphoinositides. J Cell Biol 
135, 169-79. 
 
Schwarz, M. A., Owaribe, K., Kartenbeck, J. and Franke, W. W. (1990). 
Desmosomes and hemidesmosomes: constitutive molecular components. Annu Rev Cell 
Biol 6, 461-91. 
 
Shibasaki, Y., Ishihara, H., Kizuki, N., Asano, T., Oka, Y. and Yazaki, Y. (1997). 
Massive actin polymerization induced by phosphatidylinositol-4-phosphate 5-kinase in 
vivo. J Biol Chem 272, 7578-81. 
 
Shyng, S. L., Barbieri, A., Gumusboga, A., Cukras, C., Pike, L., Davis, J. N., Stahl, 
P. D. and Nichols, C. G. (2000). Modulation of nucleotide sensitivity of ATP-sensitive 
potassium channels by phosphatidylinositol-4-phosphate 5-kinase. Proc Natl Acad Sci U 
S A 97, 937-41. 
 
Steimle, P. A., Hoffert, J. D., Adey, N. B. and Craig, S. W. (1999). 
Polyphosphoinositides inhibit the interaction of vinculin with actin filaments. J Biol 
Chem 274, 18414-20. 
 
Tolias, K. F., Hartwig, J. H., Ishihara, H., Shibasaki, Y., Cantley, L. C. and 
Carpenter, C. L. (2000). Type Ialpha phosphatidylinositol-4-phosphate 5-kinase 
mediates Rac-dependent actin assembly. Curr Biol 10, 153-6. 
 
Tsukita, S., Furuse, M. and Itoh, M. (1999). Structural and signalling molecules come 
together at tight junctions. Curr Opin Cell Biol 11, 628-33. 
 
Turner, C. E., Glenney, J. R., Jr. and Burridge, K. (1990). Paxillin: a new vinculin-
binding protein present in focal adhesions. J Cell Biol 111, 1059-68. 
 
Vicente-Manzanares, M. and Sanchez-Madrid, F. (2004). Role of the cytoskeleton 
during leukocyte responses. Nat Rev Immunol 4, 110-22. 
 
Villarejo, M. R. and Zabin, I. (1974). Beta-galactosidase from termination and deletion 
mutant strains. J Bacteriol 120, 466-74. 
 
Von Wichert, G., Haimovich, B., Feng, G. S. and Sheetz, M. P. (2003). Force-
dependent integrin-cytoskeleton linkage formation requires downregulation of focal 
complex dynamics by Shp2. Embo J 22, 5023-5035. 
 
                                                                                                                5. References 84
Weaver, A. M., Karginov, A. V., Kinley, A. W., Weed, S. A., Li, Y., Parsons, J. T. 
and Cooper, J. A. (2001). Cortactin promotes and stabilizes Arp2/3-induced actin 
filament network formation. Curr Biol 11, 370-4. 
 
Webb, D. J., Donais, K., Whitmore, L. A., Thomas, S. M., Turner, C. E., Parsons, J. 
T. and Horwitz, A. F. (2004). FAK-Src signalling through paxillin, ERK and MLCK 
regulates adhesion disassembly. Nat Cell Biol 6, 154-61. 
 
Weekes, J., Barry, S. T. and Critchley, D. R. (1996). Acidic phospholipids inhibit the 
intramolecular association between the N- and C-terminal regions of vinculin, exposing 
actin-binding and protein kinase C phosphorylation sites. Biochem J 314, 827-32. 
 
Weernink, P. A., Guo, Y., Zhang, C., Schmidt, M., Von Eichel-Streiber, C. and 
Jakobs, K. H. (2000). Control of cellular phosphatidylinositol 4,5-bisphosphate levels by 
adhesion signals and rho GTPases in NIH 3T3 fibroblasts involvement of both 
phosphatidylinositol-4-phosphate 5-kinase and phospholipase C. Eur J Biochem 267, 
5237-46. 
 
Weernink, P. A., Meletiadis, K., Hommeltenberg, S., Hinz, M., Ishihara, H., 
Schmidt, M. and Jakobs, K. H. (2004). Activation of type I phosphatidylinositol 4-
phosphate 5-kinase isoforms by the Rho GTPases, RhoA, Rac1, and Cdc42. J Biol Chem 
279, 7840-9. 
 
Weller, P. A., Ogryzko, E. P., Corben, E. B., Zhidkova, N. I., Patel, B., Price, G. J., 
Spurr, N. K., Koteliansky, V. E. and Critchley, D. R. (1990). Complete sequence of 
human vinculin and assignment of the gene to chromosome 10. Proc Natl Acad Sci U S A 
87, 5667-71. 
Wessel, D. and Flugge, U. I. (1984). A method for the quantitative recovery of protein in 
dilute solution in the presence of detergents and lipids. Anal Biochem 138, 141-3. 
 
Winkler, J., Lunsdorf, H. and Jockusch, B. M. (1996). The ultrastructure of chicken 
gizzard vinculin as visualized by high-resolution electron microscopy. J Struct Biol 116, 
270-7. 
 
Wood, C. K., Turner, C. E., Jackson, P. and Critchley, D. R. (1994). Characterisation 
of the paxillin-binding site and the C-terminal focal adhesion targeting sequence in 
vinculin. J Cell Sci 107, 709-17. 
 
Wozniak, M. A., Modzelewska, K., Kwong, L. and Keely, P. J. (2004). Focal adhesion 
regulation of cell behavior. Biochim Biophys Acta 1692, 103-19. 
 
Xu, W., Baribault, H. and Adamson, E. D. (1998a). Vinculin knockout results in heart 
and brain defects during embryonic development. Development 125, 327-37. 
 
                                                                                                                5. References 85
Xu, W., Coll, J. L. and Adamson, E. D. (1998b). Rescue of the mutant phenotype by 
reexpression of full-length vinculin in null F9 cells; effects on cell locomotion by domain 
deleted vinculin. J Cell Sci 111 ( Pt 11), 1535-44. 
 
Yamada, K. M. and Geiger, B. (1997). Molecular interactions in cell adhesion 
complexes. Curr Opin Cell Biol 9, 76-85. 
 
Yin, H. L. and Janmey, P. A. (2003). Phosphoinositide regulation of the actin 
cytoskeleton. Annu Rev Physiol 65, 761-89. 
 
Young, P. and Gautel, M. (2000). The interaction of titin and alpha-actinin is controlled 
by a phospholipid-regulated intramolecular pseudoligand mechanism. Embo J 19, 6331-
40. 
 
Zamir, E. and Geiger, B. (2001). Molecular complexity and dynamics of cell-matrix 
adhesions. J Cell Sci 114, 3583-90. 
 
Ziegler, W. H., Tigges, U., Zieseniss, A. and Jockusch, B. M. (2002). A lipid-regulated 
docking site on vinculin for protein kinase C. J Biol Chem 277, 7396-404. 
 
 
                                                                                                          6.Appendix 86
6. Appendix 
 
 
6.1. List of figures 
 
Figure 1.1:  Cell migration at a glance      6 
Figure 1.2:  Molecular model of a focal adhesion     10 
Figure 1.3:  Molecular structure of vinculin     12 
Figure 1.4 A:  Structure of vinculin tail      13 
Figure 1.4 B : Molecular surface of vinculin tail     14 
Figure 1.5:  Ligand interactions of vinculin     15 
Figure 3.1:  Schematic representation of wild type and mutant tail domains 40 
Figure 3.2:  Surface models of Vt 879-1061 wild type and LD   42 
Figure 3.3:  CD Spectroscopic analysis of Vt domains    44 
Figure 3.4:  SLV pull down assay with Vt wild type and mutants  46 
Figure 3.5:  Interaction of Vt wild type and mutants with filamentous actin 47 
Figure 3.6:  GST pull down assay for Vh – Vt interaction   48 
Figure 3.7:  Protein expression pattern in B16-F1 stable cell populations 50 
Figure 3.8:  Localization of GFP – vinculin variants in B16-F1 cells  52 
Figure 3.9:   Localization of GFP vinculin variants in C2C12 and  
NIH 3T3 cells        53 
Figure 3.10:  Staining for endogenous vinculin in MEF -/- and 
MEF +/+ cells        53 
Figure 3.11.:  Localization of GFP vinculin variants in vinculin null  
and control mouse embryonic fibroblasts     54 
Figure 3.12:  Migration assay in 3D collagen matrix    55 
Figure 3.13:   Polarization of B16-F1 populations expressing  
GFP-vinculin constructs on laminin     57 
Figure 3.14:  Time lapse video microscopy on B16-F1 cells expressing 
vinculin wt and LD       58  
Figure 3.15:  Adhesion assay with various extracellular matrices   60 
Figure 3.16:  Spreading of stable cell populations on various 
extracellular matrices       61 
Figure 3.17:  Rate of incorporation of GFP vinculin variants 
in adhesion sites       62 
Figure 3.18:  Retrograde sliding of adhesions     63 
Figure 3.19:  PIP5-kinase α expression in parental B16-F1 cells   65 
Figure 3.20:  PIP5-kinase α expression in stable B16-F1 populations 
  expressing vinculin wt and LD     66 
Figure 3.21:  L61 Rac expression in B16-F1 cells expressing  
GFP vinculin wt and LD      67 
Figure 4.1:  Model of vinculin involvement in adhesion site turnover  73 
    
 
                                                                                                          6.Appendix 87
 
 
6.2. List of tables 
 
Table 2.1: Cloning and mutagenesis primers      21 
Table 2.2: Sequencing primers       22 
Table 2.3: List of antibodies used in immuno blots     23 
Table 2.4: List of antibodies and toxins used in immuno fluorescence  24 
Table 3.1: Isoelectric points of vinculin tail domains    41 
Table 3.2: List of vinculin tail domain and vinculin head domain constructs 43 
 
 
 
 
 
 
                                                                                                     Acknowledgements                                     88
Acknowledgements 
 
I extend my sincere thanks to Prof. Dr. Brigitte M. Jockusch for granting me this great 
opportunity, to perform my doctoral thesis under her guidance. She has always been very 
encouraging and supportive to my work. Her concern and care for my personal life in 
Germany made my stay comfortable and memorable. 
 
I am grateful to Dr. Wolfgang H. Ziegler, for his wonderful supervision, encouragement, 
support and motivation throughout the study. I enjoyed working with him these three 
years and I am sure this experience will help me in my future career. 
 
I am thankful to Prof. Dr. Jürgen Wehland, GBF, Braunschweig, for his support 
throughout this work. My special thanks go to Dr. Theresia E. B. Stradal, for her 
supervision, guidance, above all, her kind and impressive behavior. I greatly 
acknowledge the help from Dr. Klemens Rottner with useful discussions and suggestions.  
 
Many thanks to Dr. Frank Entschladen, University of Witten/Herdecke for his kind help 
and support to this work. I would like to include Ms. Beate Mainusch for her good 
technical support in this regard.  
 
I am thankful to Dr. Mark R. Holt, KCL, London, for the collaboration, help and support. 
 
I thank Prof. Dr. Günter Schwarz for his kind acceptance to grade the thesis and  
Prof. Dr. R.R. Mendel for his acceptance to be involved in the thesis committee.  
 
My sincere thanks go to Dr. Björg Pauling for being a good friend, organizing the IGC, 
and for helping me with my thesis. Many thanks to Mrs. Eva Saxinger for the techincal 
assistance and good conversations. 
 
I thank PD. Dr. Susanne Illenberger and Dr. Martin Rothkegel for the useful discussions 
and support. I thank Kai Murk, Berenike Kleinhenz for the good chat and fun in the lab. 
                                                                                                     Acknowledgements                                     89
 
I am very thankful to my dear friend Jose´ Santamaria for being a good moral support and 
for influencing my personality in many good ways, especially by introducing me to the 
“western culture” and by guiding me throughout. 
 
Many thanks to dear Maryam for being a caring friend. I thank the “sweet girl” Anika 
Steffen for her guidance, love and care. 
 
My sincere thanks to all my good friends, Bhavani, Senthil, Rajesh, Harold Stiege, 
Gomathi for their love and care and for many special moments. 
 
I am grateful to my parents, especially my mother for her constant encouragement, 
support, love and trust on me which helped me to get to this stage. Thanks to my dear 
brother for his love. 
 
I am very happy to have Kamesh in my life; I thank him for his unconditional love, 
encouragement and support. 
 
